Page 1
1
1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus
bradycardia:
a) [ ] PQ interval 0.22 mm/sec
b) [ ] Irregular RR intervals
c) [ ] Atrial and ventricular frequency >70 b/min
d) [ ] QRS complex more than 0.14 mm /sec
e) [x] Atrial and ventricular frequency < 60 b/min
---------------------------------------------------------------------
2. Intrebarea nr. 2: Intrebarea2 Punctajul: 10CS. In sinusal tachycardia, all ECG signs are
present excepting
a) [ ] RR intervals equal
b) [ ] Atrial and ventricular frequency > 100 b / min
c) [x] PQ interval 0.2 sec
d) [ ] QRS complex duration 0.1 sec
e) [ ] Presence of P waves before each QRST complex
---------------------------------------------------------------------
3. Intrebarea nr. 3: Intrebarea3 Punctajul: 10CS. Tick the characteristic ECG sign of
respiratory arrhythmia:
a) [ ] QRS complex is more than 0.1 sec
b) [ ] missing P wave before QRS
c) [ ] Present of ''F'' wave between the QRST complexes
d) [x] cyclical shortening intervals R - R in inspiration
e) [ ] cyclical lengthening intervals R - R to inspiration missing
---------------------------------------------------------------------
4. Intrebarea nr. 4: Intrebarea4 Punctajul: 10CS. Mention clinical sign characteristic of
paroxysmal supraventricular tachycardia :
a) [ ] high heart frequency
b) [ ] tachycardia access begins abruptly
c) [x] tachycardia access start slow
d) [ ] vagal maneuvres stops tachycardia access
e) [ ] tachycardia access stops abrupt missing
---------------------------------------------------------------------
5. Intrebarea nr. 5: Intrebarea5 Punctajul: 10CS. Tick the characteristic ECG sign in
reciprocal atrioventricular tachycardia with acceding ways:
a) [ ] PQ interval 0.2 mm / sec
b) [x] negative P waves in DII, DIII, aVF and positive in aVR following QRS
c) [ ] irregular RR interval
d) [ ] QRS duration > 0.14 sec.
e) [ ] usually aberrant QRS complex
---------------------------------------------------------------------
6. Intrebarea nr. 6: Intrebarea6 Punctajul: 10CS. Tick the characteristic ECG sign of
paroxysmal ventricular tachycardia: a) [x] abnormal QRS complex, with secondary changes in ST, T
b) [ ] negative P wave before QRS
c) [ ] presence of delta wave
d) [ ] PQ interval <0.12 sec
Page 2
2
e) [ ] negative P waves after QRS complex
---------------------------------------------------------------------
7. Intrebarea nr. 7: Intrebarea7 Punctajul: 10CS. Tick the characteristic ECG sign for atrial
extrasistolia : a) [ ] ''f'' wave between RR intervals
b) [ ] PQ interval< 0.12 sec
c) [x] presence of premature P wave before QRST complex
d) [ ] full compensatory pause
e) [ ] absence P wave before QRST complex
---------------------------------------------------------------------
8. Intrebarea nr. 8: Intrebarea8 Punctajul: 10CS. The characteristic ECG signs of ventricular
extrasistolia are all excepting: a) [ ] normal PQ interval
b) [ ] ST segment and T wave are opposite to the main deflexion QRS complex
c) [ ] full compensatory pause
d) [x] negative P wave after QRS complex
e) [ ] QRS duration> 0.12 sec
---------------------------------------------------------------------
9. Intrebarea nr. 9: Intrebarea9 Punctajul: 10CS. Atrial flutter is characterized by the
following ECG signs excepting:
a) [ ] atrial frequency contractions 300 b / min
b) [ ] propagation of atrial impulses to the ventricles in relation 2:1
c) [ ] QRS complex usually normal
d) [ ] ''F'' wave between where RR-looking like a saw tooth
e) [x] incomplete compensatory pause
---------------------------------------------------------------------
10. Intrebarea nr. 10: Intrebarea10 Punctajul: 10CS. In paroxysm of ventricular tachycardia
with severe haemodynamic instability the method of choice is: a) [x] electric shock application 75-100 J
b) [ ] intravenous Sol. Novocainamyd
c) [ ] intravenous Sol Digoxin
d) [ ] electric shock application 50 J
e) [ ] intramuscular Sol. Lidocaine
---------------------------------------------------------------------
11. Intrebarea nr. 11: Intrebarea11 Punctajul: 10CM. ECG classification of tachyarrhythmia
includes:
a) [x] wide QRS complex tachyarrhythmia
b) [x] narrow QRS complex tachyarrhythmia
c) [ ] normal PQ interval tachyarrhythmia
d) [ ] lengthened PQ interval
e) [ ] with ST segment elevation tachyarrhythmia
---------------------------------------------------------------------
12. Intrebarea nr. 12: Intrebarea12 Punctajul: 10CM. Characteristic ECG signs of atrial
fibrillation are:
a) [x] irregular RR intervals
b) [ ] ''F'' wave between RR-looking saw tooth
Page 3
3
c) [x] absence of P-wave
d) [x] ''f'' wave between RR intervals
e) [ ] PQ interval duration 0.14 sec
---------------------------------------------------------------------
13. Intrebarea nr. 13: Intrebarea13 Punctajul: 10CM. Tick the most common causes of atrial
fibrillation:
a) [x] mitral stenosis
b) [x] thyrotoxicosis
c) [x] alcoholic cardiomyopathy
d) [ ] mixedema
e) [x] atrial septal defect type ''ostium secundum"
---------------------------------------------------------------------
14. Intrebarea nr. 14: Intrebarea14 Punctajul: 10CM. Classification of atrial fibrillation
includes: a) [ ] acute atrial fibrillation
b) [x] chronic atrial fibrillation
c) [x] paroxysmal atrial fibrillation
d) [x] persistent atrial fibrillation
e) [ ] relapsing atrial fibrillation
---------------------------------------------------------------------
15. Intrebarea nr. 15: Intrebarea15 Punctajul: 10CM. Choose correct statements of ''vagal''
paroxysmal atrial fibrillation:
a) [ ] is more frequently in women
b) [x] Standby is triggered
c) [x] is more common in men
d) [ ] It appears during emotional stress
e) [x] it begin postprandial or during sleep
---------------------------------------------------------------------
16. Intrebarea nr. 16: Intrebarea16 Punctajul: 10CM. The correct statements about
"adrenergic" paroxysmal atrial fibrillation are:
a) [x] occurs during exercise
b) [x] is caused by stressful situations
c) [x] mainly in the morning
d) [x] meets more frequently in women's
e) [ ] Standby fires
---------------------------------------------------------------------
17. Intrebarea nr. 17: Intrebarea17 Punctajul: 10CM. Tick the drugs that inhibit the impulse
driving the atrioventricular node:
a) [x] Digoxin
b) [x] Propronalol
c) [x] Amiodarone
d) [x] Verapamil
e) [ ] Nifedipine
---------------------------------------------------------------------
18. Intrebarea nr. 18: Intrebarea18 Punctajul: 10CM. Choose the medicines used to restore
sinus rhythm in a patient with atrial fibrillation:
Page 4
4
a) [ ] Digoxin
b) [x] Novocainamid
c) [x] Amiodarone
d) [x] Propafenone
e) [x] Sotalol ---------------------------------------------------------------------
19. Intrebarea nr. 19: Intrebarea19 Punctajul: 10CM. In atrial fibrillation thromboembolic
risk factors are:
a) [x] age > 60 years
b) [x] artherial hypertension
c) [x] diabetes
d) [x] history of stroke
e) [ ] overweight ---------------------------------------------------------------------
20. Intrebarea nr. 20: Intrebarea20 Punctajul: 10CM. Ventricular flluter is characterized by:
a) [x] syncop
b) [ ] ''F'' wave between RR-looking saw tooth
c) [x] absence of peripheral pulse
d) [x] presence of sinusoidal regular waves
e) [x] heart rates 250 -300 per min
---------------------------------------------------------------------
21. Intrebarea nr. 21: Intrebarea21 Punctajul: 10CM. Ventricular fibrillation is characterized
by:
a) [ ] delta waves on ECG
b) [x] lack of QRS complexes
c) [x] syncope
d) [x] presence of distorted, irregular, chaotic waves on ECG
e) [ ] presens of ''f''waves between QRS
---------------------------------------------------------------------
22. Intrebarea nr. 22: Intrebarea22 Punctajul: 10CM. Effective resuscitation measures in
ventricular fibrillation and flutter included:
a) [x] punch in the chest in the first few seconds
b) [x] initial electrical cardioversion with 200 J
c) [x] electrical cardioversion with 320 - 400 J in unloading effect
d) [x] cardiac massage correctly done in the first minutes
e) [ ] Sol. lidocaine intravenous
---------------------------------------------------------------------
23. Intrebarea nr. 23: Intrebarea23 Punctajul: 10CM. Sinus tachycardia is characterized by:
a) [x] gradually heart rate increase
b) [x] normal physiological response to physical exertion
c) [x] QRS complex is normal
d) [ ] PQ interval is more 0.20 seconds
e) [x] the pace is accelerating in inspiration and reduced on expiration
---------------------------------------------------------------------
24. Intrebarea nr. 24: Intrebarea24 Punctajul: 10CM. Tick sinus tachycardia causes:
a) [ ] vagus nerve hypertonus
Page 5
5
b) [x] alcohol abuse
c) [x] fever
d) [x] thyreotoxicosis
e) [x] cor pulmonale
---------------------------------------------------------------------
25. Intrebarea nr. 25: Intrebarea25 Punctajul: 10CM. Junctional nonparoxistic
atrioventricular tachycardia is caused by :
a) [x] cardiac glycosides poisoning
b) [x] inferior myocardial infarction
c) [x] hypocaliemia
d) [x] heart surgery intervention
e) [ ] hypocalcaemia
---------------------------------------------------------------------
26. Intrebarea nr. 26: Intrebarea26 Punctajul: 10CM. Reciprocal junctional atrioventricular
tachycardia mechanism include:
a) [x] atria and ventricles concomitant depolarization
b) [x] impulse circulating into the atrioventricular node
c) [x] anterograde ventricular activation of His - Purkijne system
d) [x] retrograde activation of the atria
e) [ ] atria depolarization precedes ventricular depolarization
---------------------------------------------------------------------
27. Intrebarea nr. 27: Intrebarea27 Punctajul: 10CM. Treatment of atrioventricular reciprocal
tachycardias include:
a) [x] vagal maneuvers application
b) [x] Face immersion in cold water with breath retention for 10-30 sec
c) [x] Sol adenosine triphosphate intravenous. 10 mg in 1 second
d) [ ] external electric shock with 200 J
e) [x] transoesophageal heart electric stimulation
---------------------------------------------------------------------
28. Intrebarea nr. 28: Intrebarea28 Punctajul: 10CM. Paroxysmal ventricular tachycardia is
characterized by:
a) [x] regular ventricular rhythm
b) [ ] effectiveness of vagal maneuvers in treatment
c) [x] abnormal QRS complex with ST,T secondary changes
d) [ ] PQ interval prolongation
e) [ ] ''f''wave with 400-700/min frequency
---------------------------------------------------------------------
29. Intrebarea nr. 29: Intrebarea29 Punctajul: 10CM. Choose antiarrhythmic drugs
administrated to stop ventricular tachycardia:
a) [ ] Digoxin
b) [x] Lidocaine
c) [x] Amiodarone
d) [x] Disopyramide
e) [x] Novocainamid
---------------------------------------------------------------------
30. Intrebarea nr. 30: Intrebarea30 Punctajul: 10CM. ECG characteristic of in atrial
Page 6
6
extrasitolia includes:
a) [x] normal QRS complex
b) [ ] lack of P wave
c) [ ] negative P wave after QRS complex
d) [x] incomplete compensatory pause
e) [x] premature P wave QRS complex precede
---------------------------------------------------------------------
31. Intrebarea nr. 31: Intrebarea31 Punctajul: 10CM. Choose polymorphic extrayistole
sfeatures:
a) [x] varying coupling intervals
b) [x] extrasistolias in the same lead have different forms
c) [ ] extrasistolias in the same lead have equal forms
d) [ ] coupling intervals are equal
e) [x] different outbreaks extrasistolias
---------------------------------------------------------------------
32. Intrebarea nr. 32: Intrebarea32 Punctajul: 10CM. Ventricular ECG extrasistolias
manifested by:
a) [x] QRS complex pathological
b) [x] full compensatory pause
c) [ ] P-Q interval less 0.12 sec
d) [ ] negative P wave, succeded QRS
e) [x] lack of P wave
---------------------------------------------------------------------
33. Intrebarea nr. 33: Intrebarea33 Punctajul: 10CM. In superior atrioventricular extrasistolia
the ECG recordes:
a) [ ] PQ interval over 0.20 sec
b) [x] normal QRS complex
c) [x] P wave negative in DII, DIII before the QRS complex
d) [ ] P wave negative in DII, DIII QRS after QRS
e) [x] incomplete compensatory pause
---------------------------------------------------------------------
34. Intrebarea nr. 34: Intrebarea34 Punctajul: 10CM. Tick the ECG manifestations of average
atrioventricular extrasistoles
a) [x] QRS complex usually normal
b) [ ] P wave negative in DII, DIII subsequent to QRS
c) [x] P wave is embedded in QRS complex
d) [x] full compensatory pause
e) [ ] P wave negative in DII, DIII precede QRS complex
---------------------------------------------------------------------
35. Intrebarea nr. 35: Intrebarea35 Punctajul: 10CM. In lower atrioventricular extrasistolia
ECG records: a) [ ] P wave failure
b) [x] normal QRS complex
c) [x] incomplete compensatory pause
d) [x] negative P wave after QRS complex
e) [ ] wide QRS complex
Page 7
7
---------------------------------------------------------------------
36. Intrebarea nr. 36: Intrebarea36 Punctajul: 10CM. Lawn-Wolf classification of
extrasistoles includes: a) [x] Class I - solitary monomorphic extrasystoles -> 30 ex / h
b) [ ] Class II - solitary extrasystoles polymorph
c) [x] Class III - polymorphyc ventricular extrasistols
d) [x] Class IV - recurrent ventricular extrasistols (duble, triples, sage)
e) [x] Class V - early ventricular type " R on T"
---------------------------------------------------------------------
37. Intrebarea nr. 37: Intrebarea37 Punctajul: 10CM. Tick I class antiarrhythmic drugs: a) [x] Lidocaine
b) [x] Mexilitin
c) [x] Quinidine
d) [x] Novocainamid
e) [ ] Amiodarone
---------------------------------------------------------------------
38. Intrebarea nr. 38: Intrebarea38 Punctajul: 10CM. Tick II class antiarrhythmic drugs:
a) [ ] Amiodarone
b) [ ] Lidocaine
c) [x] Metoprolol
d) [x] Nebivolol
e) [x] Carvedilol ---------------------------------------------------------------------
39. Intrebarea nr. 39: Intrebarea39 Punctajul: 10CM. Tick III class antiarrhythmic drugs:
a) [ ] Lidocaine
b) [x] Sotalol
c) [ ] Quinidine
d) [ ] Novocainamid
e) [x] Amiodarone
---------------------------------------------------------------------
40. Intrebarea nr. 40: Intrebarea40 Punctajul: 10CS. What disorder can not be diagnosed by
electrocardiographic conduction :
a) [ ] Atrioventricular block gr. I
b) [ ] Complete right bundle branch block of His bundle
c) [x] Sinoatrial block of gr. I
d) [ ] Atrioventricular block gr. III
e) [ ] Sinoatrial block of gr. II
---------------------------------------------------------------------
41. Intrebarea nr. 41: Intrebarea41 Punctajul: 10CS. Sinoatrial block grade II,
electrocardiographic, manifested by:
a) [x] sinusal pauses; no P wave
b) [ ] periodical lack QRS complexes
c) [ ] full compensatory pause after PQRST complex
d) [ ] frequent atrial and ventricularare contractions
e) [ ] PQ interval prolongation
---------------------------------------------------------------------
42. Intrebarea nr. 42: Intrebarea42 Punctajul: 10CS. Name conductivity disorder is
Page 8
8
characterized by ECG periods Wenckebach:
a) [ ] II degree atrioventricular block, type II (Mobitz II)
b) [x] II degree sinoatrial block, type I (Mobitz I)
c) [ ] third degree atrioventricular block
d) [ ] complete right bundle branch block of His beam
e) [ ] left bundle branch block of His beam
---------------------------------------------------------------------
43. Intrebarea nr. 43: Intrebarea43 Punctajul: 10CS. The main clinical feature of advanced
sinoatrial and atrioventricular blocks II degree type II (Mobitz II) is:
a) [ ] Palpitations
b) [ ] Dyspnea on exertion moderate or mixed
c) [ ] Fatigability
d) [x] Syncopal states
e) [ ] Constrictive retrosternal pain with iradiation below the right shoulder blade
---------------------------------------------------------------------
44. Intrebarea nr. 44: Intrebarea44 Punctajul: 10CS. Atrioventricular block gr. I is
electrocardiographic manifested by:
a) [ ] Elongated QRS Interval
b) [ ] Negative P waves before QRST complex
c) [x] PQ or PR intervals more than 0.2 sec
d) [ ] PQ intervals different
e) [ ] Where Delta
---------------------------------------------------------------------
45. Intrebarea nr. 45: Intrebarea45 Punctajul: 10CS. The atrioventricular block gr. II,
electrocardiographic, stating:
a) [ ] lack of periodic PQRST complex
b) [ ] lack of P wave
c) [x] lack regular QRS complexes
d) [ ] The presence of "F" waves
e) [ ] The presence of "f"waves
---------------------------------------------------------------------
46. Intrebarea nr. 46: Intrebarea46 Punctajul: 10CS. Characteristic sign called third degree
atrioventricular block:
a) [x] None of atrial impulses do not propagate to the ventricles
b) [ ] Gradual slowing of the propagation of impulses to the ventricles
c) [ ] Organic lesion His-Purkinje system
d) [ ] Pausing the electrical activity of sinus node
e) [ ] Impulses are conducted retrograde from the ventricles to the atria
---------------------------------------------------------------------
47. Intrebarea nr. 47: Intrebarea47 Punctajul: 10CS. Third degree atrioventricular block
electrocardiographicaly is manifested by
a) [ ] atrial contractions and ventricular ratio is 3:1
b) [x] atrial and ventricular contractions independent
c) [ ] sinus pause without P wave
d) [ ] lack of periodic PQRST complexes
e) [ ] QRST complexes lack regular
Page 9
9
---------------------------------------------------------------------
48. Intrebarea nr. 48: Intrebarea48 Punctajul: 10CS. Mentione ECG carcateristic sign of
complete right bundle branch block beam Hiss:
a) [x] presence of large R wave, crocheted in III, AVF, V1, V2
b) [ ] PQ interval prolongation
c) [ ] PQ interval shortening
d) [ ] where R wide, crocheted in I, AVL, V5, V6
e) [ ] where S is larger in III, AVF, V1, V2
---------------------------------------------------------------------
49. Intrebarea nr. 49: Intrebarea49 Punctajul: 10CS. Mentione ECG sign of complete left
bundle branch block beam Hiss:
a) [ ] presence of large R wave, crocheted in III, AVF, V1, V2
b) [ ] PQ interval prolongation
c) [ ] PQ interval shortening
d) [x] where R wide, crocheted in I, AVL, V5, V6
e) [ ] where S range in I, AVL, V5, V6
---------------------------------------------------------------------
50. Intrebarea nr. 50: Intrebarea50 Punctajul: 10CS. Mention indication to implantable
cardioverter-defibrillator:
a) [x] Ventricular fibrillation recurrences at varying intervals of time
b) [ ] Complete atrioventricular block
c) [ ] Atrial fibrillation
d) [ ] Atrial flutter
e) [ ] Complete sinoatrial block
---------------------------------------------------------------------
51. Intrebarea nr. 51: Intrebarea51 Punctajul: 10CM. Name asistolias causes:
a) [x] atrioventricular block III degree
b) [ ] atrioventricular block I degree
c) [ ] ectopic rhythm from the middle of atrioventricular junction
d) [x] complete sinoatrial block
e) [ ] chronic atrial fibrillation
---------------------------------------------------------------------
52. Intrebarea nr. 52: Intrebarea52 Punctajul: 10CM. The causes of abnormal automatism can
be:
a) [x] Extent of myocardial fibers
b) [x] Changes in electrolyte balance
c) [x] Action of catecholamines
d) [x] Myocardial infarction
e) [ ] Anemias
---------------------------------------------------------------------
53. Intrebarea nr. 53: Intrebarea53 Punctajul: 10CM. Specify the electrophysiological
mechanisms of arrhythmias
a) [ ] Decreasing of normal automatism
b) [x] Increasing of normal automatism
c) [x] Presents of pathological automatism
d) [x] Early postdepolarization
Page 10
10
e) [x] Late posdepolarizations
---------------------------------------------------------------------
54. Intrebarea nr. 54: Intrebarea54 Punctajul: 10CM. What are ECG characteristic II degrees
sinoatrial block type II (Mobitz II)
a) [ ] equal PP periods
b) [ ] incomplete compensatory pause after PQRST complex
c) [x] sinusal pause, no P wave
d) [x] pause duration corresponding to 2,3 or more PP normal intervals
e) [ ] pause is preceded by progressive decrease in PP intervals
---------------------------------------------------------------------
55. Intrebarea nr. 55: Intrebarea55 Punctajul: 10CM. Classic version of Morgan - Adams -
Stockes syndrome included:
a) [ ] hypertension
b) [x] sudden onset
c) [x] syncope with pronounced pale skin
d) [x] reactive hyperemia after exit from the crisis
e) [x] transient caracter
---------------------------------------------------------------------
56. Intrebarea nr. 56: Intrebarea56 Punctajul: 10CM. Specify the correct statements
atrioventricular block gr. I
a) [x] Keeping of all atrial impulses to the ventricles
b) [x] PQ or PR interval over 0.2 sec
c) [x] common in the elderly
d) [ ] PQ or PR interval less than 0.12 sec.
e) [ ] Gradual lengthening of the PQ interval ---------------------------------------------------------------------
57. Intrebarea nr. 57: Intrebarea57 Punctajul: 10CM. Name atrioventricular block features II
degree, type I (Mobitz I):
a) [x] Progressive lengthening of PQ or PR interval
b) [x] Omission of ventricular contraction
c) [x] The presence of Wenckebach periods Samoilov
d) [x] Irregular RR intervals
e) [ ] Regular RR intervals
---------------------------------------------------------------------
58. Intrebarea nr. 58: Intrebarea58 Punctajul: 10CM. The atrioventricular block II degree,
type II (Mobitz II) are characterised:
a) [ ] Samoilov-Wenckebach periods
b) [x] RR intervals equal
c) [x] Not all atrial impulses are propagated to the ventricles
d) [x] The ECG recorded absence of 1,2,3 …QRS complex
e) [x] Organic lesion is present in conductibility heart system
---------------------------------------------------------------------
59. Intrebarea nr. 59: Intrebarea59 Punctajul: 10CM. Frederic syndrome includes a
combination of atrial fibrillation with:
a) [ ] Atrioventricular block II degree, type II
b) [ ] Complete sinoatrial block
Page 11
11
c) [ ] Frequent atrial extrasistolia
d) [ ] Frequent ventricular extrasistolia
e) [x] complet atrioventricular block
---------------------------------------------------------------------
60. Intrebarea nr. 60: Intrebarea60 Punctajul: 10CM. Specify characteristics of third degree
atrioventricular block located in the AV node:
a) [x] It is often congenital
b) [x] In most patients AV junctional rhythm is registered with the heart rate40-60 b / min
c) [x] During exercise and stress the heart rates is accelerating up to 100 b / min
d) [ ] heart rates is not more that 40 b / min
e) [ ] It is almost always acquired
---------------------------------------------------------------------
61. Intrebarea nr. 61: Intrebarea61 Punctajul: 10CM. Specify characteristics of third degree
atrioventricular block in the system based Hiss - Purkinje:
a) [ ] It is often congenital
b) [x] Patients have syncopal states
c) [ ] During exercise and stress the heart rates is accelerating up to 100 b / min
d) [x] The frequency rate does not exceed 40 b / min
e) [x] It is almost always acquired
---------------------------------------------------------------------
62. Intrebarea nr. 62: Intrebarea62 Punctajul: 10CM. Note rhythm disorders manifested by
syncopal states:
a) [x] Ventricular fibrillation
b) [ ] Atrial fibrilation
c) [x] Ventricular flutter
d) [x] Ventricular tachycardia
e) [x] Complete atrioventricular block
---------------------------------------------------------------------
63. Intrebarea nr. 63: Intrebarea63 Punctajul: 10CM. The complete left bundle branch block
of His beam on ECG is registered:
a) [x] QRS duration exceeding 0.12 sec.
b) [x] S-ventricular complex in III, AVF, V1, V2
c) [ ] S-ventricular complex in I, AVL, V5, V6
d) [x] ventricular complex type R in I, AVL, V5, V6
e) [ ] QRS duration from 0.10 to 0.12 sec. ---------------------------------------------------------------------
64. Intrebarea nr. 64: Intrebarea64 Punctajul: 10CM. Note the ECG signs of incomplete right
bundle branch block of His beam:
a) [ ] widening of QRS complexes over 0.12 sec
b) [x] ventricular complex in leads RSR type III, AVF, V1, V2
c) [x] absence and presence of Q waves in leads V5 wide S waves, V6
d) [ ] ventricular rhythm
e) [x] QRS duration from 0.10 to 0.12 sec
---------------------------------------------------------------------
65. Intrebarea nr. 65: Intrebarea65 Punctajul: 10CM. Specify the correct statements
Wolff-Parkinson-White syndrome:
Page 12
12
a) [x] The presence of a pathway directly linking accessories atrium of the ventricles
b) [x] Atrial impulse propagated simultaneously towards node Hiss and f. Kent
c) [x] Early depolarization ventricles
d) [x] The presence of delta wave on ECG
e) [ ] PQ interval within 0.12 to 0.20 sec
---------------------------------------------------------------------
66. Intrebarea nr. 66: Intrebarea66 Punctajul: 10CM. Incomplete left bundle branch block of
His beam is characterized by:
a) [x] "R" type complex in I, AVL, V5, V6
b) [x] electric axis suddenly diverted to the left
c) [x] S complex type III, AVF, V1, V2
d) [x] QRS duration from 0.1 to 0.12 sec
e) [ ] junction rhythm
---------------------------------------------------------------------
67. Intrebarea nr. 67: Intrebarea67 Punctajul: 10CM. Wolff-Parkinson-White syndrome is
manifested on electrocardiogram by:
a) [x] The presence of delta wave
b) [x] RR intervals equal
c) [x] normal P wave and PQ interval less that 0.12 sec
d) [ ] PQ interval over 0.18 seconds
e) [ ] Progressive lengthening of the interval PQ
---------------------------------------------------------------------
68. Intrebarea nr. 68: Intrebarea68 Punctajul: 10CM. Specify the indications for implantation
of permanent cardiostimulation:
a) [x] Complete atrioventricular block associated with symptomatic bradycardia
b) [x] Frederick Syndrome
c) [x] Recurrent syncope associated with systolic intervals over 3 sec.
d) [x] Atrioventricular block gr. II persistent after previous myocardial infarction
e) [ ] Ventricular fibrillation
---------------------------------------------------------------------
69. Intrebarea nr. 69: Intrebarea69 Punctajul: 10CM. Rhythm disorders indicate that you use
transesophageal electrocardiostimulation:
a) [x] Atrial flutter
b) [x] Paroxysmal AV reciprocal tachycardia
c) [ ] Ventricular fibrillation
d) [ ] Ventricular Flutter
e) [ ] Bifascicular block
---------------------------------------------------------------------
70. Intrebarea nr. 70: I429 Punctajul: 10CM. What conduction disorders can be diagnosed
electrocardiographically:
a) [x] I-st degree atrioventricular block
b) [x] Complete right bundle branch block
c) [ ] I-st degree sinoatrial block
d) [x] III-rd degree atrioventricular block
e) [x] II-nd degree sinoatrial block
---------------------------------------------------------------------
Page 13
13
71. Intrebarea nr. 71: I430 Punctajul: 10CM. Second degree sinoatrial block, is manifested
on EKG by:
a) [x] Sinusal rest periodswithout P waves
b) [x] Periodic lack of PQRS complexes
c) [ ] Complete compensatory pause after PQRST complex
d) [ ] Frequent atrial and ventricular contractions
e) [ ] PQ intervalelongation
---------------------------------------------------------------------
72. Intrebarea nr. 72: I431 Punctajul: 10CM. Call the conduction disorders characterized
electrocardiographicallyby Wenckebach periods:
a) [x] II-nd degree sinoatrial block, tiype I (Mobitz I)
b) [x] II-nd degree sinoatrial block, tip II (Mobitz II)
c) [ ] III-rd degree atrioventricular block
d) [ ] Complete right bundle branch block
e) [ ] Left bundle branch block
---------------------------------------------------------------------
73. Intrebarea nr. 73: I432 Punctajul: 10CM. Clinical II-nd degree sinoatrial and
atrioventricular Type II (Mobitz II) are manifested by:
a) [ ] Palpitations
b) [ ] Exertional mixed dyspnea at moderate stress
c) [x] Presyncope
d) [x] Syncope
e) [ ] Constrictive chest pain withirradiation under the right shoulder. ---------------------------------------------------------------------
74. Intrebarea nr. 74: I433 Punctajul: 10CM. I-st degree AV block is manifested
electrocardiographycally by:
a) [ ] Prolonged QRS interval
b) [ ] Negative P wavesbefore QRST complexes
c) [x] PQ or PR intervals more than 0,2sec
d) [x] Egal PQ intervals
e) [ ] Delta waves
---------------------------------------------------------------------
75. Intrebarea nr. 75: I434 Punctajul: 10CM. II-nd degree AV block is manifested
electrocardiographycally by:
a) [x] Periodical lack of QRST complex
b) [ ] Abcence of P wave
c) [x] Solitaire P wave without ORSTcomplex
d) [ ] "f" waves
e) [ ] "F" waves
---------------------------------------------------------------------
76. Intrebarea nr. 76: I435 Punctajul: 10CM. Call the characteristic signs of the III-rd degree
atrioventricular block:
a) [x] None of atrial impulses passto ventricles
b) [x] Independent atrial and ventricular contractions
c) [ ] Organic lesion of sinoatrial node
d) [ ] Temporary stop of the electrical activity of the sinus node
Page 14
14
e) [ ] Impulses are conducted retrograde from ventricles to the atria
---------------------------------------------------------------------
77. Intrebarea nr. 77: I436 Punctajul: 10CM. III-rd degree AV block is manifested
electrocardiographycally by:
a) [x] Contracții atriale și ventriculare independente
b) [x] Morgan - Adams - Stocssindrom
c) [x] Syncope
d) [ ] Periodical lack of PQRST complexes
e) [ ] Periodical lack of QRST complexes
---------------------------------------------------------------------
78. Intrebarea nr. 78: Intrebarea70 Punctajul: 10CS. Infective endocarditis is a disease:
a) [ ] Degenerative
b) [ ] Destructive
c) [x] Infectious
d) [ ] Congenital
e) [ ] Inherited two
---------------------------------------------------------------------
79. Intrebarea nr. 79: I71 Punctajul: 10CS. Infective endocarditis most rare involved:
a) [ ] Mitral valve
b) [ ] Aortic valve
c) [ ] Tricuspid valve
d) [ ] Pulmonary artery valve
e) [x] Eustache valve
---------------------------------------------------------------------
80. Intrebarea nr. 80: I72 Punctajul: 10CS. Note predominantly infectious agent in
intravenous drug users and patients with prosthetic valves:
a) [ ] Streprococcus virdans
b) [ ] Streptococcus β hemolytic
c) [x] Staphylococcus aureus
d) [ ] Staphylococcus epidermal
e) [ ] Enterococcocus fecalis
---------------------------------------------------------------------
81. Intrebarea nr. 81: I73 Punctajul: 10CS. The first description of infectious endocarditis
belongs to:
a) [ ] E. Libman
b) [x] W. Osler
c) [ ] H. Schottmuller
d) [ ] W. Thayer's
e) [ ] S. Jaccoud
---------------------------------------------------------------------
82. Intrebarea nr. 82: I74 Punctajul: 10CS Treatment of infectious endocarditis includes the
following drugs excluding:
a) [ ] Antibiotics
b) [ ] Antifungal
c) [ ] Cardiac glycosides
d) [x] Anticoagulants
Page 15
15
e) [ ] β-blockers
---------------------------------------------------------------------
83. Intrebarea nr. 83: I75 Punctajul: 10CS. Note the dose of Amoxaciline used in secondary
prophylaxis of infection endocarditis:
a) [ ] 500 mg / day to 2 hours before dental procedure
b) [ ] 500 mg / day after the dental procedure
c) [x] 2 g 30-min- 1 hour before procedure
d) [ ] 1 g / day to 2 hours before dental procedure
e) [ ] 500 mg / day in 4 divided doses
---------------------------------------------------------------------
84. Intrebarea nr. 84: I76 Punctajul: 10CS. Methicillin-resistant streptococcal endocarditis is
exclusively treated with:
a) [ ] Penicillin G
b) [ ] Ceftriaxone
c) [x] Vancomycin
d) [ ] Gentamicin is.
e) [ ] Amoxaciline
---------------------------------------------------------------------
85. Intrebarea nr. 85: I77 Punctajul: 10CS. Name the most common and most serious
complication of infectious endocarditis:
a) [ ] Embolic events
b) [x] Heart failure "Osler" type
c) [ ] Glomerulonephritis
d) [ ] Encephalitis
e) [ ] Toxic hepatitis
---------------------------------------------------------------------
86. Intrebarea nr. 86: I78 Punctajul: 10CS. Name the most informative laboratory tests in
infective endocarditis:
a) [ ] Full blood
b) [ ] Urea
c) [ ] C-reactive protein
d) [x] Blood culture
e) [ ] Urine culture
---------------------------------------------------------------------
87. Intrebarea nr. 87: I79 Punctajul: 10CM. Vegetatations in endocarditis are localized on:
a) [x] Native valves
b) [x] Valve Eustache
c) [ ] Ileocecal valve
d) [x] Prosthetic valves
e) [x] Ventricular septal defect ---------------------------------------------------------------------
88. Intrebarea nr. 88: I80 Punctajul: 10CM. Major criteria for diagnosis of infective
endocarditis are:
a) [ ] Fever ≥ 38 C
b) [ ] Fever ≤ 38 C
c) [x] Positive blood culture in three peripheral veins
Page 16
16
d) [ ] Positive blood cultures from a single sample
e) [x] The presence of vegetation on echocardiography
---------------------------------------------------------------------
89. Intrebarea nr. 89: I81 Punctajul: 10CM. Note the key clinical manifestations of infectious
endocarditis
a) [ ] Diarrhea
b) [ ] Vomiting
c) [x] Chills
d) [x] Increased sweating
e) [x] Fever
---------------------------------------------------------------------
90. Intrebarea nr. 90: I82 Punctajul: 10CM. The predominant right heart endocarditis has
following complications:
a) [x] Septic pneumonia
b) [x] Destructive multifocal pneumonia
c) [ ] Cerebral embolism
d) [ ] Coronary embolism
e) [x] Pulmonar abscess
---------------------------------------------------------------------
91. Intrebarea nr. 91: I83 Punctajul: 10CM. Note specific embolic complications of left heart
endocarditis:
a) [x] Renal emboli
b) [x] Cerebral embolism
c) [x] Splenic embolism
d) [x] Renal emboli
e) [ ] Trombembolias
---------------------------------------------------------------------
92. Intrebarea nr. 92: I84 Punctajul: 10CM. Primary prophylaxis of infectious endocarditis
is obligatory in patients with:
a) [ ] Mitral valve prolapse
b) [ ] Ischemic Heart Diseases
c) [x] Hypertrophic cardiomyopathy
d) [x] Prosthetic valves
e) [x] Infective endocarditis in antecedence
---------------------------------------------------------------------
93. Intrebarea nr. 93: I85 Punctajul: 10CM. Infective endocarditis is considered active in the
following cases:
a) [x] In the first two months of the onset
b) [x] Persistent fever regardless of disease duration
c) [x] Endocardial inflammation by morphological examination proving
d) [x] Positive blood cultures
e) [ ] Pathogenic detection in smears from the nasopharynx
---------------------------------------------------------------------
94. Intrebarea nr. 94: I86 Punctajul: 10CM. Name corrects statements of prosthesis
endocarditis early:
a) [x] Staphylococci and streptococci are predominant infectious agents'
Page 17
17
b) [x] Embolic complications are the cause high rate mortality
c) [x] Develops in the first 12 months after valve replacement
d) [ ] Develops in the first 24 months after valve replacement
e) [x] Also is called nosocomial endocarditis
---------------------------------------------------------------------
95. Intrebarea nr. 95: I87 Punctajul: 10CM. The treatment of heart failure in endocarditis
included:
a) [x] Surgical correction of the valvulopathy
b) [x] Glycosides
c) [x] Diuretics
d) [ ] Glucocorticosteroids
e) [x] Angiotensin Converting Inhibitors
---------------------------------------------------------------------
96. Intrebarea nr. 96: I88 Punctajul: 10CM. Note the indication to surgical treatment of
infectious endocarditis:
a) [x] Fungal endocarditis
b) [ ] Streptococcal endocarditis
c) [x] Complicated by Myocardial abscess
d) [ ] Infective endocarditis complicated by glomerulonephritis
e) [x] Resistant to antibacterial therapy
---------------------------------------------------------------------
97. Intrebarea nr. 97: I437 Punctajul: 10CM. Infectious endocarditis is a disease:
a) [x] infectious
b) [x] with vegetante lesions on native valves
c) [x] dehiscence ofprosthesis
d) [x] with positive blood cultures
e) [ ] with positive smear from nasopharynx
---------------------------------------------------------------------
98. Intrebarea nr. 98: I438 Punctajul: 10CM. Infectious endocarditis is affecting:
a) [x] native valves
b) [x] mechanical prosthetic valves
c) [x] biological prosthetic valves
d) [x] intact valves
e) [ ] ileocecale valves
---------------------------------------------------------------------
99. Intrebarea nr. 99: I439 Punctajul: 10CS. Name the predominant infectious agent
ofinfectious endocarditis of the prosthesis:
a) [ ] Streprococcusvirdans
b) [ ] Streptococcusbovis
c) [ ] Enterococulfaecalis
d) [ ] Staphiylococcus epidermidis
e) [x] Staphiylococcus aureus
---------------------------------------------------------------------
100. Intrebarea nr. 100: I440 Punctajul: 10CS. Name the predominant infectious agent
ofinfectious endocarditisof intravenous drug users:
a) [ ] Staphiylococcus epidermidis
Page 18
18
b) [x] Staphiylococcus aureus
c) [ ] Streprococcus virdans
d) [ ] Streptococcus bovis
e) [ ] Enterococul faecalis
---------------------------------------------------------------------
101. Intrebarea nr. 101: I441 Punctajul: 10CS. Name the predominant infectious agent
ofinfectious endocarditisin patients who do not take care of dental hygiene:
a) [x] Streprococcus virdans
b) [ ] Streptococcus bovis
c) [ ] Enterococul faecalis
d) [ ] Staphiylococcus epidermidis
e) [ ] Staphiylococcus aureus
---------------------------------------------------------------------
102. Intrebarea nr. 102: I442 Punctajul: 10CM. Notethe scientists who have dealt with
research in the field of infectious endocarditis:
a) [x] E. Libman
b) [x] W. Osler
c) [x] H. Schottmuller
d) [ ] L. Nicolaev
e) [ ] V. Socoteanu
---------------------------------------------------------------------
103. Intrebarea nr. 103: I443 Punctajul: 10CM. Treatment of infectious endocarditis include
the following drugs:
a) [x] Antibiotics
b) [x] Antifungal
c) [x] Cardiac glycosides
d) [ ] Anticoagulants
e) [x] Beta blockers
---------------------------------------------------------------------
104. Intrebarea nr. 104: I444 Punctajul: 10CS. Name the treatment dose and managementof
administration of Daptomycin in patients with infectious endocarditis caused by Staphylococcus
aureus:
a) [x] 500 mg / day intravenous infusion
b) [ ] 1g / day intravenous bolus
c) [ ] 3 g/day orally
d) [ ] 1 g/day orally
e) [ ] 500 mg / day in 4 divided doses intramuscularly
---------------------------------------------------------------------
105. Intrebarea nr. 105: I445 Punctajul: 10CS. Name the dose of Vancomycin treatment in
patients with infectious endocarditis caused by staphylococci meticilinresistant:
a) [ ] 500 mg / day intravenous infusion
b) [ ] 1 g / day intravenous infusion
c) [x] 2 g / day intravenous infusion in 2 doses
d) [ ] 500 mg / day intravenous bolus
e) [ ] 1 g / day intravenous bolus
---------------------------------------------------------------------
Page 19
19
106. Intrebarea nr. 106: I446 Punctajul: 10CM. Staphylococcal infectious endocarditis
meticilin-resistancetreated with:
a) [ ] Penicillin G
b) [x] Daptomycin
c) [x] Vancomycin
d) [ ] Gentamicin
e) [ ] Amoxicillin
---------------------------------------------------------------------
107. Intrebarea nr. 107: I447 Punctajul: 10CM. Name the complications of infectious
endocarditis:
a) [x] glomerulonephritis
b) [x] embolisms
c) [x] heart failure
d) [ ] torticolism
e) [x] toxic hepatitis
---------------------------------------------------------------------
108. Intrebarea nr. 108: I448 Punctajul: 10CM. Name the most informative investigations in
the diagnosis of infectious endocarditis:
a) [x] Echocardiography
b) [ ] Electrocardiography
c) [ ] C-reactive protein
d) [x] Blood culture
e) [ ] Uroculture
---------------------------------------------------------------------
109. Intrebarea nr. 109: I449 Punctajul: 10CS. Microbial infectious endocarditis in graft is
localiazează on the valve with the exception of the following:
a) [ ] native valves
b) [ ] Eustachian valve
c) [x] ileocecal valve
d) [ ] valvular prostheses
e) [ ] intact valves
---------------------------------------------------------------------
110. Intrebarea nr. 110: I450 Punctajul: 10CM. The major criteria for the diagnosis of infective
endocarditis are:
a) [ ] Fever ≥ 380C
b) [x] Myocardial abscess on echocardiography
c) [x] Positive blood culture in three peripheral veins
d) [x] Dehiscence of prosthesis at echocardiography
e) [x] The presence of vegetations on echocardiography
---------------------------------------------------------------------
111. Intrebarea nr. 111: I451 Punctajul: 10CS. In right heart infectious endocarditis develops
embolism:
a) [x] Pulmonare with septic pneumonia
b) [ ] Coronary
c) [ ] Cerebrals
d) [ ] Mezenteriale
Page 20
20
e) [ ] Splenic
---------------------------------------------------------------------
112. Intrebarea nr. 112: I452 Punctajul: 10CS. Note the embolic complications specific left heart
infectious endocarditis except:
a) [ ] Renal embolisms
b) [ ] Cerebral embolisms
c) [ ] Splenic embolisms
d) [ ] Coronary embolisms
e) [x] Pulmonary embolisms with abscesses
---------------------------------------------------------------------
113. Intrebarea nr. 113: I453 Punctajul: 10CM. Infectious endocarditis prophylaxis isnecessary in
patients with:
a) [ ] Mitral valve prolapse
b) [ ] Ischemic cardiopathya
c) [x] Hypertrophic cardiopathy
d) [x] Valvular prostheses
e) [x] Infectious endocarditis in the past ---------------------------------------------------------------------
114. Intrebarea nr. 114: I454 Punctajul: 10CM. Infectious endocarditis is active in the following
cases:
a) [x] In the first two months of the onset of her
b) [x] The presence of positive blood cultures and persistent fever regardless of disease duration
c) [x] Proving endocardial inflammation by morphological examination
d) [x] Pathogen detection by positive blood cultures
e) [ ] The detection of the pathogen through the smear from nasopharynx
---------------------------------------------------------------------
115. Intrebarea nr. 115: I455 Punctajul: 10CM. Name the correct statements for early prosthesis
infectious endocarditis:
a) [x] The predominant infectious agents ofinfectious endocarditisare staphylococci and
streptococci
b) [x] Embolic complications is a high percentage and cause death
c) [x] Develops in the first 6 months after prosthesis
d) [ ] Infectious endocarditis is called community
e) [x] Infectious endocarditis is also called nosocomial endocarditis
---------------------------------------------------------------------
116. Intrebarea nr. 116: I456 Punctajul: 10CM. Treatment of heart failure in infectious endocarditis
is performed by:
a) [x] Surgical correction of valvulopathy
b) [x] Administration of cardiac glycosides
c) [x] Administration of diuretics
d) [ ] Administration of glucocorticosteroids
e) [x] Administration of vasodilators
---------------------------------------------------------------------
117. Intrebarea nr. 117: I457 Punctajul: 10CM. Surgical treatment of infectious endocarditis is
indicated in:
a) [x] Fungal endocarditis
Page 21
21
b) [ ] Streptococcal endocarditis
c) [x] Infectious endocarditis complicated with myocardial abscess
d) [ ] Infectious endocarditis complicated with glomerulonephritis
e) [x] Infection resistant to antibacterial treatment ---------------------------------------------------------------------
118. Intrebarea nr. 118: I458 Punctajul: 10CM. Minor criteria for diagnosis of infectious
endocarditis are:
a) [x] Fever ≥ 380C
b) [x] Positive blood culture of a serological test
c) [ ] Dehiscence of prosthesis at echocardiography
d) [x] Suspectionof vegetation on echocardiography
e) [x] Predisposing cardiac factors
---------------------------------------------------------------------
119. Intrebarea nr. 119: I459 Punctajul: 10CM. Minor criterias DUKE for establishing the
diagnosis of infectious endocarditis are:
a) [x] Fever ≥ 380C
b) [x] Janeway lesions
c) [ ] Positive blood culture in three peripheral veins
d) [x] Osler nodules
e) [ ] The presence of vegetations on echocardiography
---------------------------------------------------------------------
120. Intrebarea nr. 120: I460 Punctajul: 10CM. Minor criterias DUKE for establishing the
diagnosis of infectious endocarditis are:
a) [x] Fever ≥ 380C
b) [x] Rheumatoid factor positive
c) [ ] Positive blood culture in three peripheral veins
d) [x] Roth spots
e) [ ] The presence of vegetations on echocardiography
---------------------------------------------------------------------
121. Intrebarea nr. 121: I461 Punctajul: 10CM. In infectious endocarditismicrobial graft is located
onfollowing cardiac structures:
a) [x] Native valves
b) [x] Valvularcordages
c) [ ] Carotid arteries
d) [x] The ejection of the aorta
e) [ ] Femoral arteries
---------------------------------------------------------------------
122. Intrebarea nr. 122: I462 Punctajul: 10CS. Name the correct statements for the late prosthesis
infectious endocarditis:
a) [ ] The predominant agents are staphylococci
b) [ ] Embolic complications is a high percentage and cause death
c) [ ] Develops in the first 6 months after prosthesis
d) [x] Infectious endocarditis is called community
e) [ ] Infectious endocarditis is also called nosocomial endocarditis
---------------------------------------------------------------------
123. Intrebarea nr. 123: I463 Punctajul: 10CM. Name the correct statements for the late prosthesis
Page 22
22
infectious endocarditis:
a) [ ] The predominant agents are staphylococci
b) [ ] Embolic complications is a high percentage and cause death
c) [x] Develops in the first 1 year after prosthesis
d) [x] Infectious endocarditis is called community
e) [ ] Infectious endocarditis is also called nosocomial endocarditis
---------------------------------------------------------------------
124. Intrebarea nr. 124: I464 Punctajul: 10CM. Name the new forms of infectious endocarditis:
a) [x] Intracardiacc devices of infectious endocarditis
b) [ ] Infectious endocarditis in the adolescence
c) [x] Infectious endocarditis in the elderly
d) [x] Infectious endocarditis of the intravenous drug users
e) [ ] Infectious endocarditis of addicts
---------------------------------------------------------------------
125. Intrebarea nr. 125: I465 Punctajul: 10CS. Name the new forms of infectious endocarditis
except:
a) [ ] Intracardiacc devices of infectious endocarditis
b) [x] Infectious endocarditis in the adolescence
c) [ ] Infectious endocarditis in the elderly
d) [ ] Infectious endocarditis of the intravenous drug users
e) [ ] Infectious endocarditis in patients on hemodialysis
---------------------------------------------------------------------
126. Intrebarea nr. 126: I466 Punctajul: 10CM. Name the cardiac predisposing factors for
developing infectious endocarditis:
a) [x] Congenital heart diseases
b) [x] Degenerative heart diseases
c) [x] Hypertrophic heart diseases
d) [ ] Hypertension
e) [ ] Myocardial infarction
---------------------------------------------------------------------
127. Intrebarea nr. 127: I467 Punctajul: 10CM. Name the cardiac predisposing factors for
developing infectious endocarditis:
a) [x] Bicuspid aortic valve
b) [x] Mitral stenosis
c) [x] Ventricular septal defect
d) [ ] Hypertension
e) [x] Mitral valve prolapse
---------------------------------------------------------------------
128. Intrebarea nr. 128: I468 Punctajul: 10CS. Name the most common predisposing factor for the
development of infectious endocarditis in the Republic of Moldova:
a) [ ] Intact valves
b) [x] Rheumatic valvulopathy
c) [ ] Myocarditis
d) [ ] Hypertension
e) [ ] Hypertrophic heart diseases
---------------------------------------------------------------------
Page 23
23
129. Intrebarea nr. 129: I469 Punctajul: 10CS. Name the predisposing factor for the development of
infectious endocarditis of right heart:
a) [ ] Dental extractions
b) [ ] Viral hepatitis
c) [ ] Hypertrophic heart diseases
d) [x] Intravenous drug use
e) [ ] Rheumatic heart disease
---------------------------------------------------------------------
130. Intrebarea nr. 130: I470 Punctajul: 10CM. Name the morbid circumstances (the gateway to
infection) in infectious endocarditis:
a) [x] Pneumonia
b) [x] Dental extractions
c) [x] Hemodialysis
d) [x] Poor dental hygiene
e) [ ] Old age
---------------------------------------------------------------------
131. Intrebarea nr. 131: I471 Punctajul: 10CS. Name the most frequent gateway of infectious
endocarditis of right heart:
a) [ ] Respiratory infections
b) [ ] Dental extractions
c) [x] Intravenous drug use
d) [ ] Poor dental hygiene
e) [ ] Old age
---------------------------------------------------------------------
132. Intrebarea nr. 132: I472 Punctajul: 10CM. Name the most common comorbidities that
predispose to the development of infectious endocarditis in patients from Moldova.
a) [x] Liver cirrhosis
b) [x] Hepatitis
c) [x] Diabetes
d) [ ] AIDS
e) [ ] Lues
---------------------------------------------------------------------
133. Intrebarea nr. 133: I473 Punctajul: 10CS. How many weeks of antimicrobial therapy requires
patient with streptococcal infectious endocarditis?
a) [ ] 1 week
b) [ ] 2 weeks
c) [ ] 3 weeks
d) [x] 4 weeks
e) [ ] 6 weeks
---------------------------------------------------------------------
134. Intrebarea nr. 134: I474 Punctajul: 10CS. How many weeks of antimicrobial therapy requires
patient prosthesis infectious endocarditis, with staphylococcal etiology?
a) [ ] 1 week
b) [ ] 4 weeks
c) [ ] 6 weeks
d) [x] 8 weeks
Page 24
24
e) [ ] 10 weeks
---------------------------------------------------------------------
135. Intrebarea nr. 135: I475 Punctajul: 10CS. Infectious endocarditis is considered to be cured in
the following cases:
a) [x] Final eradication of infection
b) [x] Normal body temperature
c) [x] ESR in normal and negative blood cultures within 1 year after completion of the treatment
d) [ ] ESR in normal and negative blood cultures within 1 month after completion of the treatment
e) [ ] ESR in normal and negative blood cultures within 6 months after completion of the
treatment ---------------------------------------------------------------------
136. Intrebarea nr. 136: I89 Punctajul: 10CS. Marks the most used laboratory investigation for
diagnosis of rheumatic heart diseases:
a) [ ] Electrocardiography
b) [x] Echocardiography
c) [ ] Phonocardiographs
d) [ ] Cardiac CT
e) [ ] MRI of the heart ---------------------------------------------------------------------
137. Intrebarea nr. 137: I90 Punctajul: 10CS. Choose uncharacteristic complication of mitral
regurgitation:
a) [ ] Atrial fibrillation
b) [ ] Endocarditis
c) [ ] Systemic embolism
d) [x] Stomach bleeding
e) [ ] Cardiac Asthma
---------------------------------------------------------------------
138. Intrebarea nr. 138: I91 Punctajul: 10CS. Treatment of manifest mitral regurgitation does not
include:
a) [ ] ACE inhibitors
b) [ ] Beta blockers
c) [ ] Diuretics
d) [ ] Cardiac glycosides
e) [x] Alfa mimetic drugs
---------------------------------------------------------------------
139. Intrebarea nr. 139: I92 Punctajul: 10CS. Marks the most common rhythm disorder in mitral
stenosis:
a) [ ] Sinus bradycardia
b) [ ] Ventricular Extrasistolia
c) [x] Atrial fibrillation
d) [ ] Ventricular fibrillation
e) [ ] Atrioventricular blocks
---------------------------------------------------------------------
140. Intrebarea nr. 140: I93 Punctajul: 10CS. Tick the cause of typical angina attacks mitral
stenosis
a) [ ] Increased blood flow to the heart
Page 25
25
b) [ ] Sudden increase in blood in the capillaries
c) [ ] Congestions in small circuit
d) [x] Left coronary artery compression by increased left atrium
e) [ ] Right coronary artery compression by increased right atrium
---------------------------------------------------------------------
141. Intrebarea nr. 141: I94 Punctajul: 10CS. Specify normal hole surface of aorta
a) [x] 2,5 - 3,0 cm2
b) [ ] 2,0 - 2,5 cm2
c) [ ] 3,5 - 4,0 cm2
d) [ ] 1,5 - 2,0 cm2
e) [ ] 3,0 - 4,0 cm2
---------------------------------------------------------------------
142. Intrebarea nr. 142: I95 Punctajul: 10CS. Mention wich kind of valvulopathy causing severe
left ventricular concentric hypertrophy:
a) [ ] Mitral stenosis
b) [x] aortic stenosis
c) [ ] Mitral valve regurgitation
d) [ ] Aortic valve regurgitation
e) [ ] Pulmonary artery regurgitation
---------------------------------------------------------------------
143. Intrebarea nr. 143: I96 Punctajul: 10CS. Mention wich valvulopathy can reach values the
diastolic blood pressure to 60-0 mmHg.
a) [ ] Aortic stenosis.
b) [ ] Mitral stenosis
c) [ ] Pulmonary artery stenosis
d) [ ] Mitral valve regurgitation
e) [x] Aortic valve regurgitation
---------------------------------------------------------------------
144. Intrebarea nr. 144: I97 Punctajul: 10CS. Mention the norms of ejection fraction
a) [x] 50 %
b) [ ] 80-100%
c) [ ] 90-95%
d) [ ] 40-60%
e) [ ] 20-30%
---------------------------------------------------------------------
145. Intrebarea nr. 145: I98 Punctajul: 10CS. Specify the norms for the right atrium diameter size:
a) [x] 20-40 mm
b) [ ] 15 - 20 mm
c) [ ] 40-50 mm
d) [ ] 10 - 20 mm
e) [ ] 50-60 mm
---------------------------------------------------------------------
146. Intrebarea nr. 146: I99 Punctajul: 10CS. Specify the norms for left atrium size.
a) [ ] 10 - 20 mm
b) [ ] 15- 20 mm
c) [x] 20-40 mm
Page 26
26
d) [ ] 40-50 mm
e) [ ] 50-60 mm
---------------------------------------------------------------------
147. Intrebarea nr. 147: I100 Punctajul: 10CM. Mitral regurgitation is caused by:
a) [x] Mitral valve calcification and fibrosis
b) [x] Rupture of mitral cusp
c) [x] Cordage rupture
d) [x] Papillary muscle rupture
e) [ ] The decrease of mitral orifice area
---------------------------------------------------------------------
148. Intrebarea nr. 148: I101 Punctajul: 10CM. Pathology in mitral valvular regurgitation is
characterized by:
a) [x] Incomplete closure of the mitral cusps
b) [ ] The decrease of mitral orifice area
c) [x] Thickening and shortening of trends chords
d) [ ] Cusps fusion
e) [x] Inflammatory and sclerotic changes in mitral ring
---------------------------------------------------------------------
149. Intrebarea nr. 149: I102 Punctajul: 10CM. Marks the Mentioned changes in heart auscultation
in mitral regurgitation:
a) [ ] Noise I snapped apex
b) [x] Noise I fell apex
c) [x] Systolic murmur at the apex
d) [ ] Diastolic murmur at the apex
e) [ ] Diastolic murmur at aorta
---------------------------------------------------------------------
150. Intrebarea nr. 150: I103 Punctajul: 10CM. Enumerates ECG characteristics of severe mitral
regurgitation:
a) [x] Left atrium hypertrophy
b) [x] Horizontal or left deviation electric cord axe
c) [x] Left ventricle hypertrophy
d) [x] Atrial fibrillation
e) [ ] Righ atrium hypertrophy
---------------------------------------------------------------------
151. Intrebarea nr. 151: I104 Punctajul: 10CM. Marks the clinical characteristics of patients with
mitral insufficiency are:
a) [x] Inspiratory dyspnea on exertion
b) [x] Palpitations
c) [x] Cardiac asthma attacks
d) [ ] Syncopal states
e) [ ] Constrictive retrosternal pain of short duration, dependent exercise
---------------------------------------------------------------------
152. Intrebarea nr. 152: I105 Punctajul: 10CM.Choose the pathologic changes in mitral stenosis
are characterized by:
a) [ ] Incomplete closure of the deformity mitral cusps
b) [x] Fusion corner
Page 27
27
c) [ ] Thickening and shortening of trends hordes
d) [x] Cusps fusion
e) [ ] Inflammatory and sclerotic changes and mitral ring
---------------------------------------------------------------------
153. Intrebarea nr. 153: I106 Punctajul: 10CM. Mentioned changes to heart auscultation for the
mitral stenosis are:
a) [x] Noise I snapped apex
b) [ ] Noise I fell apex
c) [ ] Systolic murmur at the apex
d) [x] Diastolic murmur at the apex
e) [x] Noise mitral valve opening
---------------------------------------------------------------------
154. Intrebarea nr. 154: I107 Punctajul: 10CM. Characteristic ECG signs for mitral stenosis are:
a) [x] Left atrium hypertrophy
b) [ ] horizontal or left electrical axis deviation
c) [x] Right ventricle hypertrophy
d) [x] Atrial fibrillation
e) [ ] Left Ventricle hypertrophy
---------------------------------------------------------------------
155. Intrebarea nr. 155: I108 Punctajul: 10CM. Clinical characteristics of patients with mitral
stenosis are:
a) [x] Inspiratory dyspnea on exertion
b) [ ] Expiratory dyspnea at rest
c) [x] Cardiac asthma attacks
d) [ ] Syncopal states
e) [ ] Constrictive retrosternal pain of short duration
---------------------------------------------------------------------
156. Intrebarea nr. 156: I109 Punctajul: 10CM. Specify the correct statements of severe mitral
stenosis
a) [ ] Mitral orifice area is less than 1. 5 cm
b) [x] Mitral orifice area is less than 1 cm
c) [ ] Mitral orifice area is less than 2 cm
d) [x] The average pressure in left atrium is above 30 mmHg
e) [ ] Average pressure in left atrium is 20 mmHg
---------------------------------------------------------------------
157. Intrebarea nr. 157: I110 Punctajul: 10CS. Note the most common cardiomyopathy
a) [ ] Arrhythmogenic
b) [x] Dilated
c) [ ] Hypertrophic
d) [ ] Restrictive
e) [ ] Alcoholic
---------------------------------------------------------------------
158. Intrebarea nr. 158: I111 Punctajul: 10CS. What is mostly worse in dilated cardiomyopathy:
a) [x] Systole
b) [ ] Diastole
c) [ ] Blood pressure
Page 28
28
d) [ ] Pulse
e) [ ] Peripheral resistance
---------------------------------------------------------------------
159. Intrebarea nr. 159: I112 Punctajul: 10CS. Specify values сharacteristic ejection fraction in
patients with dilated cardiomyopathy:
a) [ ] 70%
b) [ ] 60%
c) [ ] 50%
d) [ ] 100%
e) [x] 25-39%
---------------------------------------------------------------------
160. Intrebarea nr. 160: I113 Punctajul: 10CS. Mentioned characteristic echocardiography changes
dilated cardiomyopathy:
a) [x] Dilation of all cardiac cavities
b) [ ] Isolated left ventricular dilation
c) [ ] Increase ejection fraction
d) [ ] Isolated right ventricular dilatation
e) [ ] Interventricular septum hypertrophy
---------------------------------------------------------------------
161. Intrebarea nr. 161: I114 Punctajul: 10CS. What is mostly worse in hypertrophic
cardiomyopathy:
a) [ ] Systole
b) [x] Diastole
c) [ ] Blood pressure
d) [ ] Pulse
e) [ ] Peripheral resistance
---------------------------------------------------------------------
162. Intrebarea nr. 162: I115 Punctajul: 10CS. Mentions echocardiography changes in hypertrophic
cardiomyopathy:
a) [ ] Dilatation of all cardiac cavities
b) [ ] Left atrial dilation
c) [ ] Increase ejection fraction
d) [ ] Isolated right ventricular dilatation
e) [x] Interventricular septum hypertophy
---------------------------------------------------------------------
163. Intrebarea nr. 163: I116 Punctajul: 10CS. Morphological substrate in restrictive
cardiomyopathy is characteristed by:
a) [x] Diffuse, marked thickening of endocardial and parietal left ventricle sometimes right
ventricle
b) [ ] Left ventricle hypertrophy
c) [ ] Cardiomegaly
d) [ ] Efilation (thin) right ventricle walls
e) [ ] Spongy myocardium
---------------------------------------------------------------------
164. Intrebarea nr. 164: I117 Punctajul: 10CS. Morphological substrate in arrhythmogenic
cardiomyopathy is characteristed by:
Page 29
29
a) [ ] Diffuse, marked thickening of endocardial and parietal left ventricle sometimes right
ventricle
b) [ ] Left ventricle hypertrophy
c) [ ] Cardiomegaly
d) [x] Efilation (thin) right ventricle walls
e) [ ] Spongy myocardium
---------------------------------------------------------------------
165. Intrebarea nr. 165: I118 Punctajul: 10CS. Mentions which cardiomyopathy has effective
treatment and favorable prognosis:
a) [ ] Hypertrophic cardiomyopathy
b) [x] Alcoholic cardiomyopathy
c) [ ] Dilated cardiomyopathy
d) [ ] Restrictive cardiomyopathy
e) [ ] Arrhythmogenic cardiomyopathy
---------------------------------------------------------------------
166. Intrebarea nr. 166: I119 Punctajul: 10CM. Note of hemodynamic changes that occurred in
dilated cardiomyopathy
a) [x] Decrease in LV ejection fraction
b) [x] Systolic flow reduction
c) [x] Heart chamber volumes increases
d) [x] Intracavitary pressure is increased
e) [ ] Increased ejection fraction
---------------------------------------------------------------------
167. Intrebarea nr. 167: I120 Punctajul: 10CM. Note the most informative methods to diagnose
cardiomyopathy:
a) [x] Myocardial biopsy
b) [x] Echocardiography
c) [ ] Phonocardiographs
d) [x] Electrocardiography
e) [x] Monitoring - ECG
---------------------------------------------------------------------
168. Intrebarea nr. 168: I121 Punctajul: 10CM. What medications will manage in dilated
cardiomyopathy:
a) [x] Diuretics
b) [x] ACE inhibitors
c) [x] Antiarrhythmics
d) [x] Anticoagulants
e) [ ] Antipyretic
---------------------------------------------------------------------
169. Intrebarea nr. 169: I122 Punctajul: 10CM. Mentions the forms of hypertrophic
cardiomyopathy.
a) [x] Obstructive
b) [x] Nonbstructive
c) [x] Apical
d) [ ] Restrictive
e) [ ] Dilated
Page 30
30
---------------------------------------------------------------------
170. Intrebarea nr. 170: I123 Punctajul: 10CM. Mentioned characteristic of clinical manifestations
in patients with hypertrophic cardiomyopathy with outflow tract obstruction:
a) [x] Dyspnoea inspiratory
b) [x] Constrictive retrosternal pain exercise independent
c) [x] Syncopal states
d) [x] Heart palpitations
e) [ ] Anasarca
---------------------------------------------------------------------
171. Intrebarea nr. 171: I124 Punctajul: 10CM. ECG changes in dilated cardiomyopathy listed?
a) [x] LV hypertrophy
b) [x] Complete left bundle block af. His
c) [x] Atrial fibrillation
d) [x] Pathological Q-waves unknown
e) [ ] Low Voltage
---------------------------------------------------------------------
172. Intrebarea nr. 172: I125 Punctajul: 10CM. Note ECG changes characteristic of hypertrophic
cardiomyopathy:
a) [x] LV hypertrophy
b) [x] Voltage increased
c) [x] Atrial fibrillation
d) [x] Pathological Q-waves in leads lower-side
e) [ ] Low Voltage
---------------------------------------------------------------------
173. Intrebarea nr. 173: I126 Punctajul: 10CM. Treatment of patients with obstructive hypertrophic
cardiomyopathy does not include
a) [x] Cardiac glycosides
b) [ ] Beta blockers
c) [x] Nitrates
d) [ ] Diuretics
e) [ ] Antiarrhythmics
---------------------------------------------------------------------
174. Intrebarea nr. 174: I127 Punctajul: 10CM. ECG changes in dilated cardiomyopathy listed?
a) [x] LV hypertrophy
b) [ ] Complete left bundle block af. His
c) [x] Atrial fibrillation
d) [x] Pathological Q-waves unknown
e) [x] Low Voltage
---------------------------------------------------------------------
175. Intrebarea nr. 175: I128 Punctajul: 10CM. List surgical methods used to treat patients with
significant obstructive hypertrophic cardiomyopathy
a) [x] Partial Mioectomia
b) [x] Septal ablation with alcohol
c) [x] First septal embolization
d) [x] Defibrillator Implantation - cardiovertel
e) [ ] Total Mioectomia
---------------------------------------------------------------------
Page 31
31
176. Intrebarea nr. 176: I129 Punctajul: 10CM. ECG changes in dilatated cardiomyopathy listed?
a) [x] LV hypertrophy
b) [ ] Complete left bundle block af. His
c) [x] Atrial fibrillation
d) [x] Pathological Q-waves inecsplicabile
e) [x] Low Voltage
---------------------------------------------------------------------
177. Intrebarea nr. 177: I130 Punctajul: 10CM. Mentions the pathologies that can develop the
restrictive cardiomyopathy:
a) [x] Endomyocardial fibrosis, eosinophilia (Loffler's syndrome)
b) [x] Cardiac amyloidosis
c) [ ] Systemic lupus erythematosus
d) [x] Hemochromatosis
e) [x] Cardiac lesions by irradiation
---------------------------------------------------------------------
178. Intrebarea nr. 178: I131 Punctajul: 10CM. Note the main causes of death in patients with
cardiomyopathy:
a) [ ] Atrial fibrillation
b) [x] Ventricular fibrillation
c) [x] Thromboembolism
d) [x] Progressive heart failure
e) [x] Sudden death
---------------------------------------------------------------------
179. Intrebarea nr. 179: I132 Punctajul: 10CS. Choose the most common and studied myocarditis
a) [x] Viral
b) [ ] Fungal
c) [ ] Toxic
d) [ ] Bacterial
e) [ ] Radiation
---------------------------------------------------------------------
180. Intrebarea nr. 180: I133 Punctajul: 10CS. Choose the most useful and informative method to
diagnose myocarditis is:
a) [ ] Electrocardiography
b) [x] Echocardiography
c) [ ] Radiography heart
d) [ ] Coronary angiography
e) [ ] Phonocardiographs
---------------------------------------------------------------------
181. Intrebarea nr. 181: I134 Punctajul: 10CS. The histological form of viral myocarditis is an
inflammatory infiltrate with predominance of
a) [ ] Monocytes
b) [x] Cell
c) [ ] Eosinophils
d) [ ] Polymorphonuclear cells is
e) [ ] Neutrofiles
---------------------------------------------------------------------
Page 32
32
182. Intrebarea nr. 182: I135 Punctajul: 10CS. Marks the characteristic electrocardiographic sign of
myocarditis:
a) [ ] negative T wave in all leads
b) [ ] LV hypertrophy and RV
c) [x] Small QRS voltage
d) [ ] Hypertrophy AS and AD
e) [ ] Complete block RAM as the His bundle
---------------------------------------------------------------------
183. Intrebarea nr. 183: I136 Punctajul: 10CS. Propose the standard criteria for diagnose
myocarditis is:
a) [ ] Echocardiography
b) [x] Endomyocardial biopsy
c) [ ] Coronary angiography
d) [ ] Myocardial scintigraphy with technetium - 99
e) [ ] Pharmacological tests in June. ---------------------------------------------------------------------
184. Intrebarea nr. 184: I137 Punctajul: 10CS. What drugs are contraindicated in acute myocarditis:
a) [ ] Diuretics
b) [ ] Angiotensin converting enzyme inhibitors II
c) [ ] Antiarrhythmic medication
d) [x] NSAIDs
e) [ ] Immunoglobulin
---------------------------------------------------------------------
185. Intrebarea nr. 185: I138 Punctajul: 10CM. Specify the name of the main mechanisms of
cardiac damage in myocarditis:
a) [x] myocardial cell damage caused by invasion of the infection
b) [x] immunologically mediated myocardial damage
c) [x] direct action of toxins on the myocardium
d) [ ] subendocardial myocarditis
e) [ ] neirohormonal activation
---------------------------------------------------------------------
186. Intrebarea nr. 186: I139 Punctajul: 10CM. Enumerate arrhythmias that can be found in
myocarditis:
a) [ ] complete sinoatrial block
b) [x] extrasistolie ventricular
c) [x] atrial tachycardia
d) [x] atrial fibrillation is
e) [x] sinus tachycardia
---------------------------------------------------------------------
187. Intrebarea nr. 187: I140 Punctajul: 10CM. Mentioned clinical manifestations characteristic for
diffuse myocarditis:
a) [x] Inspiratory dyspnea
b) [x] Fatigability
c) [x] Palpitations
d) [ ] Constrictive retrosternal pain is violent
e) [ ] Syncopal states
Page 33
33
---------------------------------------------------------------------
188. Intrebarea nr. 188: I141 Punctajul: 10CM. Marks wich clinical syndromes are interested in
myocarditis:
a) [ ] respiratory failure.
b) [x] heart failure.
c) [x] Chest pain
d) [x] Arrhythmias
e) [ ] hepatic
---------------------------------------------------------------------
189. Intrebarea nr. 189: I142 Punctajul: 10CM. Tick which cardiac specific ferments are
investigated in myocarditis are:
a) [x] Creatininfosfokinaza - izoenzyma MB
b) [x] Lactate - izoenzyma I
c) [x] Troponin I
d) [ ] Alanine aminotransferase
e) [ ] β - lipoproteide
---------------------------------------------------------------------
190. Intrebarea nr. 190: I143 Punctajul: 10CM. Name forms myocarditis:
a) [ ] parasitic
b) [ ] fungal
c) [x] Infectious
d) [x] idiopathic
e) [x] autoimmune
---------------------------------------------------------------------
191. Intrebarea nr. 191: I144 Punctajul: 10CM. Mention non-infectious causes of myocarditis:
a) [x] Autoimmune diseases
b) [x] Drug hypersensitivity by
c) [x] toxins
d) [x] Radiation
e) [ ] Q Fever
---------------------------------------------------------------------
192. Intrebarea nr. 192: I145 Punctajul: 10CM. Electrocardiographic changes typical of
myocarditis are:
a) [x] The decrease of QRS voltage
b) [x] Cardiac arrhythmias
c) [x] Heart block
d) [ ] Signs of right ventricular hypertrophy is
e) [ ] Right atrium hypertrophy
---------------------------------------------------------------------
193. Intrebarea nr. 193: I146 Punctajul: 10CM. The complication of myocarditis are:
a) [x] Arrhythmias
b) [x] Conduction abnormalities
c) [x] Congestive heart failure
d) [x] Thromboembolism
e) [ ] Left ventricle aneurysm
---------------------------------------------------------------------
194. Intrebarea nr. 194: I147 Punctajul: 10CM. The Dallas criteria, morphologically, of active
Page 34
34
myocarditis is presented by:
a) [ ] Poor infiltrated
b) [x] Inflammatory cell abundent infiltration
c) [x] Myocyte necrosis
d) [ ] Normomiocarditis
e) [ ] Myocyte degeneration
---------------------------------------------------------------------
195. Intrebarea nr. 195: I148 Punctajul: 10CM. Laboratory tests in myocarditis presents by:
a) [ ] B12 deficient anemia
b) [x] C-reactive protein
c) [x] Circulating immune complexes
d) [x] Increase myocardial enzyme activity is
e) [ ] Hypochromic anemia
---------------------------------------------------------------------
196. Intrebarea nr. 196: I149 Punctajul: 10CM. Tick what medication used in the treatment of acute
staphylococcal myocarditis?
a) [x] Diuretics
b) [x] Inhibitors of angiotensin converting enzyme II
c) [x] Immunoglobulin
d) [x] Antiarrhythmics
e) [ ] Corticosteroids
---------------------------------------------------------------------
197. Intrebarea nr. 197: I150 Punctajul: 10CM. Choose the drugs that increase viral replication in
acute myocarditis:
a) [x] Corticosteroids
b) [x] Antiinflamatory drugs
c) [ ] Antibiotics
d) [ ] Antiarrhythmics
e) [ ] Diuretics
---------------------------------------------------------------------
198. Intrebarea nr. 198: I151 Punctajul: 10CM. Note the treatment of congestive heart failure
patients with myocarditis include:
a) [x] Diuretics
b) [ ] Corticosteroids
c) [x] Digital
d) [x] Inhibitors of angiotensin converting enzyme II is
e) [ ] Vitamins
---------------------------------------------------------------------
199. Intrebarea nr. 199: I1 Punctajul: 10CS. Note the type of syncope ,that is most frequently met:
a) [ ] Orthostatic hypotension
b) [ ] Cardiac arrhythmias
c) [x] Neurogenic mediated
d) [ ] Structural cardiopulmonary diseases
e) [ ] Syncope of unknown origin
---------------------------------------------------------------------
200. Intrebarea nr. 200: I2 Punctajul: 10CS.Name the situation when the syncope is neurally
Page 35
35
mediated:
a) [x] Produced by prolonged standing
b) [ ] Primary arrhythmic ca
c) [ ] Diabetes
d) [ ] Traumatic disorders of the spinal cord
e) [ ] Cardiac arrhythmias
---------------------------------------------------------------------
201. Intrebarea nr. 201: I3 Punctajul: 10CS.Name the condition when the situational syncope
appears:
a) [ ] Primary autonomic failure
b) [ ] Secondary autonomic failure
c) [x] Produced by gastrointestinal stimulation, urination, weight lifting
d) [ ] Occurs without triggers
e) [ ] Hypovolaemia: bleeding, diarrhea, vomiting
---------------------------------------------------------------------
202. Intrebarea nr. 202: I4 Punctajul: 10CS. Orthostatic classic hypotension represents:
a) [ ] Immediately reduction of the blood pressure in standing with over 40mmHg
b) [ ] Progressive decrease of the systolic blood pressure in standing
c) [ ] Sinus tachycardia rhythm with the frequency at least 30 bpm above the resting frequency
or over 120bpm
d) [x] Decrease of the systolic blood pressure by at least 20mmHg and diastolic blood pressure of
at least 10mmHg within 3 min of standing
e) [ ] Occurs in situations of chronic fatigue syndrome
---------------------------------------------------------------------
203. Intrebarea nr. 203: I5 Punctajul: 10CS. Which of the preparations listed may cause orthostatic
hypotension:
a) [ ] Anticoagulants
b) [x] Diuretics
c) [ ] Antiarrhythmics
d) [ ] Antidiabetics
e) [ ] NSAIDs
---------------------------------------------------------------------
204. Intrebarea nr. 204: I6 Punctajul: 10CS. Orthostatic hypotension occurrs more frequently:
a) [ ] At the adult population
b) [x] At the elderly patients
c) [ ] At the young women
d) [ ] At the adolescents
e) [ ] At the young men
---------------------------------------------------------------------
205. Intrebarea nr. 205: I7 Punctajul: 10CS. Syncope through sinus carotid hypersensitivity occurs:
a) [x] At a sudden movement of the head, closely tie knot
b) [ ] Produced by swallowing, defecation, visceral pain
Page 36
36
c) [ ] Emotional stress
d) [ ] Instrumental manipulations
e) [ ] During or immediately after the swallowing
---------------------------------------------------------------------
206. Intrebarea nr. 206: I8 Punctajul: 10CS. What are the most common causes of cardiac syncope:
a) [ ] Hypovolaemia: bleeding, diarrhea, vomiting
b) [ ] Structural Heart Disease: valvular diseases, myocardial infarction or ischemia
c) [x] Rhytm and conduct disorders
d) [ ] Pulmonary valve stenosis
e) [ ] Dissection
---------------------------------------------------------------------
207. Intrebarea nr. 207: I9 Punctajul: 10CS. What is the first and mandatory investigation in the
diagnosis of syncope:
a) [ ] Eco-Doppler
b) [x] Electrocardiogram (ECG)
c) [ ] Holter ECG Monitoring
d) [ ] Test of the inclined table
e) [ ] Coronary angiography
---------------------------------------------------------------------
208. Intrebarea nr. 208: I10 Punctajul: 10CS. The most common type of syncope is:
a) [x] Reflex syncope
b) [ ] Syncope caused by structural heart disease
c) [ ] Orthostatic hypotension
d) [ ] Cardiac syncope caused by arrhythmias
e) [ ] The hypersensitivity syndrome of the carotid sinus
---------------------------------------------------------------------
209. Intrebarea nr. 209: I11 Punctajul: 10CM. Write the suspicious clinical signs for a cardiac
syncope:
a) [x] The presence of an organic heart pathology
b) [x] Onset with exertion or supine
c) [x] Palpitations during the syncope
d) [ ] Nauseas
e) [ ] Vertigos
---------------------------------------------------------------------
210. Intrebarea nr. 210: I12 Punctajul: 10CM. Write the suspicious clinical signs for a nesyncope
fall :
a) [x] The presence of the post-critical disorientation
b) [x] Tonic-clonic seizures, which begin with the access
c) [x] Frequent hits with multiple somatic complaints, without organic heart damage
d) [x] The association of the fall with vertigo
e) [x] The association of the fall with dysarthria, diplopia
---------------------------------------------------------------------
211. Intrebarea nr. 211: I13 Punctajul: 10CM. Write the suspicious ECG signs of the cardiac
syncope:
Page 37
37
a) [x] Branch block
b) [x] AV block gr. II Mobitz
c) [x] Sinus bradycardia <50 bpm
d) [x] WPW
e) [x] QT prolonged
---------------------------------------------------------------------
212. Intrebarea nr. 212: I14 Punctajul: 10CM. What factors increase the possibility that a rhythm
disorder causes the syncope
a) [x] Heart rate too low
b) [x] Heart rate too quick
c) [ ] Left ventricular function with normal ejection fraction
d) [x] Left ventricular function with low ejection fraction
e) [ ] Ventricular arrhythmia
---------------------------------------------------------------------
213. Intrebarea nr. 213: I15 Punctajul: 10CM. The structural heart diseases that cause syncope are:
a) [ ] Atrial fibrillation
b) [x] Hipertrophic cardiomyopathy
c) [x] Aortic stenosis
d) [x] Mitral stenosis
e) [ ] Supraventricular extrasystole
---------------------------------------------------------------------
214. Intrebarea nr. 214: I16 Punctajul: 10CM. What diagnostic tests have an informative value in
the evaluation of the syncope:
a) [x] Massage of the carotid sinus
b) [x] Tilt-test
c) [x] ECG term monitoring (Holter, implantable devices)
d) [x] Electrophysiological studies
e) [x] Echocardiography
---------------------------------------------------------------------
215. Intrebarea nr. 215: I17 Punctajul: 10CM. For the evaluation of the neurogenic mediated
syncope is performed:
a) [x] Carotid sinus massage
b) [x] Tilt-test
c) [ ] ECG term monitoring (Holter, implantable devices)
d) [ ] Electrophysiological studies
e) [ ] Echocardiography
Page 38
38
---------------------------------------------------------------------
216. Intrebarea nr. 216: I18 Punctajul: 10CM. Carotid sinus massage test will be considered
positive at the:
a) [x] Combination of asystole> 3 sec. and / or decrease of the systolic blood pressure> 50 mm.
b) [x] Sugestive clinical symptoms
c) [ ] The presence of post-critical disorientation
d) [ ] Tonic-clonic seizures, which begin with the access
e) [ ] Palpitations during the syncope
---------------------------------------------------------------------
217. Intrebarea nr. 217: I19 Punctajul: 10CM. What diagnostic tests have low informative value in
evaluating the syncope:
a) [ ] Tilt-test
b) [ ] Lasting ECG monitoring
c) [x] Electroencephalography
d) [x] Magnetic Resonance Imaging
e) [x] Brain CT
---------------------------------------------------------------------
218. Intrebarea nr. 218: I20 Punctajul: 10CM. Diagnostic criteria for neurogenic mediated syncope
are:
a) [x] Lack of cardiac pathology
b) [ ] Recent history of syncope
c) [x] Onset after emotions, finding long in crowded places, prolonged orthostasis
d) [x] The presence of nausea, lightheadedness before syncope
e) [x] Syncope at 1 hour after eating
---------------------------------------------------------------------
219. Intrebarea nr. 219: I21 Punctajul: 10CM. The following statements are correct for performing
carotid sinus massage:
a) [x] The patients> 40 years
b) [x] The unidentified genesis in syncope (after initial assessment)
c) [ ] It performs cardiac syncope genesis
d) [x] It performs supine position / standing
Page 39
39
e) [x] It is performed under ECG monitoring, BP for 5-10sec
---------------------------------------------------------------------
220. Intrebarea nr. 220: I22 Punctajul: 10CM. The following statements for the Tilt - test are true:
a) [x] It is shown in diagnosing the syncopes of unindentified genesis
b) [x] It is shown in particular to patients with intact heart
c) [x] Positive test (loss of consciousness with induction of hypotension and / or bradycardia) is
considered the diagnosis for the vasovagal syncope
d) [ ] Positive test (loss of consciousness with induction of hypertension)
e) [ ] Positive test (loss of consciousness with induction of tachycardia
---------------------------------------------------------------------
221. Intrebarea nr. 221: I23 Punctajul: 10CM. Complete evaluation of a patient with syncope may
require:
a) [x] Specific neurological investigations
b) [x] Psychiatric evaluation
c) [x] Coronary angiographie
d) [x] Test with adenosine triphosphate
e) [x] Intracardiac electrophysiological study
---------------------------------------------------------------------
222. Intrebarea nr. 222: I24 Punctajul: 10CM. When do we hospitalize a patient with syncope?
a) [x] When we suppose the genesis of the cardiac syncope
b) [x] Syncopa is followed by a severe trauma
c) [x] Syncopa with high recurrence
d) [ ] Single syncopal episodes
e) [ ] Episodic syncope without risk factors
---------------------------------------------------------------------
223. Intrebarea nr. 223: I25 Punctajul: 10CM. Patients will receive the following treatment:
a) [x] Single syncopal episodes without risk factors
b) [x] Frequent syncopes that affect the quality of life
c) [x] Syncope without premonitory period with an exposure to the trauma,
d) [x] High-risk activities (driving cars, machine operators, drivers and others. A.)
e) [x] Arrhythmic syncope with vital risk
Page 40
40
---------------------------------------------------------------------
224. Intrebarea nr. 224: I26 Punctajul: 10CM. For the treatment of cardiac syncope are true the
statements:
a) [x] Implantation of the electrocardiostimulator in syncope due to a AV block
b) [x] Implantation of the electrocardiostimulator increases the survival and prevents the
recurrence of syncope at the patients with heart block
c) [x] Implantation of the electrocardiostimulator will be considered at the patients with branch
block and syncope (the suspected intermittent AV block)
d) [x] Ventricular tachycardia is suspected as a cause of syncope in patients with left ventricular
dysfunction
e) [x] Supraventricular tachycardia usually do not induce syncope
---------------------------------------------------------------------
225. Intrebarea nr. 225: I27 Punctajul: 10CM. In which cases is shown the test of the tilted table?
a) [ ] In patients with organic structural heart diseases
b) [x] In patients with one syncope , but with a high risk of trauma
c) [x] To differentiate between reflex syncope and orthostatic hypotension
d) [x] To differentiate between syncope and epilepsy with tonic-clonic movements
e) [ ] Is indicated for the assessment of the treatment ---------------------------------------------------------------------
226. Intrebarea nr. 226: I28 Punctajul: 10CM. What statements are correct for the test with inclined
table with a pharmacological challenge?
a) [x] The test is highly specific, for more than 90%.
b) [ ] It is performed with dopamine i.v
c) [x] It is used isoproterenol injection i.v
d) [x] It is used 300-400 mg sublingual nitroglycerin
e) [x] It is performed 20 minutes after the base phase of the test
---------------------------------------------------------------------
227. Intrebarea nr. 227: I29 Punctajul: 10CM. Indications of the electrophysiological studies in
patients with syncope are:
a) [ ] Reflex syncope
b) [x] Ischemic heart disease in suggesting an arrhythmia as the cause of a syncope
c) [x] The syncope is preceded by palpitations, but the noninvasive studies have failed
objectification of the diagnosis
Page 41
41
d) [x] Brugada syndrome
e) [x] Arrhythmogenic right ventricular cardiomyopathy or hypertrophic cardiomyopathy
---------------------------------------------------------------------
228. Intrebarea nr. 228: I30 Punctajul: 10CM. Which statements are correct for syncope in the
elderly?
a) [x] Syncope is more common than in the general population and increases with the age
b) [x] Rapid atrial fibrillation is a causal factor for the syncope in elderly
c) [x] Diuretic therapy may cause syncope
d) [ ] Therapy with beta blockers can cause syncope
e) [x] Neurological diseases can cause syncope
---------------------------------------------------------------------
229. Intrebarea nr. 229: I31 Punctajul: 10CM. What diagnostic tests have an informative value in
the evaluation of the syncope:
a) [x] Massage of the carotid sinus
b) [x] Tilt-test
c) [x] ECG term monitoring (Holter, implantable devices)
d) [x] Electrophysiological studies
e) [ ] Electroencephalography (EEG)
---------------------------------------------------------------------
230. Intrebarea nr. 230: I32 Punctajul: 10CM. For the evaluation of the neurogenic mediated
syncope is not performed:
a) [ ] Carotid sinus massage
b) [ ] Tilt-test
c) [x] ECG term monitoring (Holter, implantable devices)
d) [x] Electrophysiological studies
e) [x] Echocardiography
---------------------------------------------------------------------
231. Intrebarea nr. 231: I33 Punctajul: 10CM. For neurogenic mediated syncope are not diagnostic
criteria:
a) [ ] Lack of cardiac pathology
b) [x] Recent history of syncope
Page 42
42
c) [ ] Onset after emotions, finding long in crowded places, prolonged orthostasis
d) [ ] The presence of nausea, lightheadedness before syncope
e) [x] Syncope at 6 hour after eating
---------------------------------------------------------------------
232. Intrebarea nr. 232: I34 Punctajul: 10CM. The following statements are correct for performing
carotid sinus massage:
a) [ ] The patients < 40 years
b) [x] The unidentified genesis in syncope (after initial assessment)
c) [ ] It performs cardiac syncope genesis
d) [x] It performs supine position / standing
e) [x] It is performed under ECG monitoring, BP for 5-10sec
---------------------------------------------------------------------
233. Intrebarea nr. 233: I35 Punctajul: 10CM. The following statements for the Tilt - test are not
true:
a) [ ] It is shown in diagnosing the syncopes of unindentified genesis
b) [ ] It is shown in particular to patients with intact heart
c) [ ] Positive test (loss of consciousness with induction of hypotension and / or bradycardia) is
considered the diagnosis for the vasovagal syncope
d) [x] Positive test (loss of consciousness with induction of hypertension)
e) [x] Positive test (loss of consciousness with induction of tachycardia
---------------------------------------------------------------------
234. Intrebarea nr. 234: I36 Punctajul: 10CM. When do we not hospitalize a patient with syncope?
a) [ ] When we suppose the genesis of the cardiac syncope
b) [ ] Syncopa is followed by a severe trauma
c) [ ] Syncopa with high recurrence
d) [x] Single syncopal episodes
e) [x] Episodic syncope without risk factors
---------------------------------------------------------------------
235. Intrebarea nr. 235: I37 Punctajul: 10CM. Which statements are correct for syncope in the
elderly?
a) [ ] Syncope is more common than in the general population and increases with the age
Page 43
43
b) [ ] Rapid atrial fibrillation is a causal factor for the syncope in elderly
c) [x] Trimetazidine therapy may cause syncope
d) [x] Therapy with beta blockers can cause syncope
e) [ ] Neurological diseases can cause syncope
---------------------------------------------------------------------
236. Intrebarea nr. 236: I38 Punctajul: 10CS. Indicate the clinical sign,that is not characteristic for
the sudden cardiac death:
a) [ ] It is natural death
b) [ ] Death of cardiac disease
c) [ ] The sudden loss of consciousness
d) [ ] Occurs within one hour of the onset of acute symptoms
e) [x] Occurs within two hours after the onset of acute symptoms
---------------------------------------------------------------------
237. Intrebarea nr. 237: I39 Punctajul: 10CS.In the definition of the sudden cardiac death we
identify four elements that succeed, except the:
a) [ ] Prodroms
b) [ ] The onset of the final event
c) [x] Respiratory failure
d) [ ] Cardiac arrest
e) [ ] Biological death
---------------------------------------------------------------------
238. Intrebarea nr. 238: I40 Punctajul: 10CS. For the biological death claims are correct the
sentences except the:
a) [ ] It is an immediate consequence of cardiac arrest
b) [ ] It is the failure of resuscitation
c) [ ] It is the absence of mechanical activity / electrical of the cord / of the central nervous
system after the resuscitation
d) [x] It is only the absence of mechanical activity / electrical of the heart after the resuscitation
e) [ ] Usually occurs within some minutes after the cardiac arrest
---------------------------------------------------------------------
Page 44
44
239. Intrebarea nr. 239: I41 Punctajul: 10CS. What is the characteristic for the premonitory
symptoms in the sudden cardiac death:
a) [x] They are often absent and nonspecific
b) [ ] They are often well expressed and specific
c) [ ] They have an insidious onset
d) [ ] They don't lead to cardiac imminent arrest
e) [ ] The occur in an interval longer than one hour
---------------------------------------------------------------------
240. Intrebarea nr. 240: I42 Punctajul: 10CS. Which statement is correct for the sudden cardiac
death:
a) [x] It constitutes approximately 60% of all deaths from cardiac cause
b) [ ] It constitutes approximately 75% of all deaths from cardiac cause
c) [ ] It constitutes approximately 65% of all deaths from cardiac cause
d) [ ] It constitutes approximately 50% of all deaths from cardiac cause
e) [ ] It constitutes approximately 80% of all deaths from cardiac cause
---------------------------------------------------------------------
241. Intrebarea nr. 241: I43 Punctajul: 10CS. Tick the prevalence of sudden cardiac death by
gender:
a) [x] It is more common in males
b) [ ] It is more common in females
c) [ ] It has the same frequency in both sexes
d) [ ] It is more common in the elderly
e) [ ] It increases progressively the proportion of young people who die suddenly
---------------------------------------------------------------------
242. Intrebarea nr. 242: I44 Punctajul: 10CS.Which statement is incorrect for the sudden cardiac
death:
a) [ ] Prevalence by age group has two peaks
b) [ ] Prevalence in the newborn period
c) [ ] The prevalence in the elderly (75-85 years)
d) [ ] In recent years gradually increase the proportion of women who die suddenly
e) [x] It increases progressively the proportion of young people who die suddenly
---------------------------------------------------------------------
243. Intrebarea nr. 243: I45 Punctajul: 10CS. Risk factors for sudden cardiac death are the
Page 45
45
following, except:
a) [ ] Myocardial Ischaemia
b) [ ] Hypertension
c) [ ] Smoking
d) [ ] Obesity
e) [x] Mitral valve prolapse
---------------------------------------------------------------------
244. Intrebarea nr. 244: I46 Punctajul: 10CS. Mention the most important cause for the sudden
cardiac death:
a) [ ] Cardiomyopathies
b) [ ] Mechanical Heart Diseases
c) [x] Coronary atherosclerotic disease
d) [ ] Electrical cardiac diseases
e) [ ] Congenital heart disease
---------------------------------------------------------------------
245. Intrebarea nr. 245: I47 Punctajul: 10CS. The most important predictor of the risk of sudden
cardiac death has been shown:
a) [ ] Diabetes mellitus
b) [ ] The elongation of the ventricular repolarization
c) [x] Severe left ventricular systolic dysfunction (EF <35%)
d) [ ] Low social economical status
e) [ ] Genetics
---------------------------------------------------------------------
246. Intrebarea nr. 246: I48 Punctajul: 10CS. What elements causes the electrical abnormalities
(long QT syndrome, Brugada syndrome) in patients with sudden cardiac death:
a) [ ] Scar zones
b) [ ] Left ventricular hipertrophy
c) [ ] Cracked plaque
d) [ ] Cord structurally normal
e) [x] Occlusive thrombus
Page 46
46
---------------------------------------------------------------------
247. Intrebarea nr. 247: I49 Punctajul: 10CS. Which statement is incorrect for the diabetes in
combination with sudden cardiac death:
a) [ ] The presence of accelerated forms of atherosclerosis
b) [ ] The increase of the thrombogenicity
c) [ ] Diabetic cardiomyopathy
d) [ ] QT prolongation in diabetic patients
e) [x] Mitral valve prolapse
---------------------------------------------------------------------
248. Intrebarea nr. 248: I50 Punctajul: 10CM. Choose the key elements in the diagnosis of sudden
cardiac death are, except:
a) [x] The traumatic character
b) [ ] The natural character (non-traumatic)
c) [ ] Rapid (within 1 hour)
d) [x] Insidious
e) [ ] Unexpected (sudden)
---------------------------------------------------------------------
249. Intrebarea nr. 249: I51 Punctajul: 10CM. What malignant ventricular tachyarrhythmias can
cause sudden cardiac death:
a) [ ] Electromechanical dissociation
b) [x] Ventricular fibrillation
c) [ ] Idioventricular rhythm
d) [ ] Bradycardia
e) [x] Sustained ventricular tachycardia
---------------------------------------------------------------------
250. Intrebarea nr. 250: I52 Punctajul: 10CM. Mention the pathologies that can cause sudden
cardiac death:
a) [x] Hypertrophic Cardiomyopathy
b) [x] Arrhythmogenic right ventricular cardiomyopathy
c) [x] Brugada syndrome
d) [x] Aortic stenose
e) [x] Myocardial bridges
---------------------------------------------------------------------
251. Intrebarea nr. 251: I53 Punctajul: 10CM. Indicate the mechanisms by which the coronary
atherosclerotic lesions cause an electrical instability, malignant ventricular tachyarrhythmias
Page 47
47
and sudden cardiac death:
a) [x] Transformation of the stable atherosclerotic plaques into instable active plate acute that
leads to acute or subacute ischemia with the production of the electrical faults in the myocardium
b) [x] Increased oxygen consumption in the presence of a significant coronary stenosis
c) [x] The presence of myocardial infarction scars at the appearance of the reentrant circuits
d) [x] Ventricular remodeling of ischemic heart disease with progressive left ventricular
dysfunction with neuro-hormonal activation of a cardiac failure
e) [ ] The diffuse myocardial affection modulated by metabolic abnormalities (anoxia, acidosis,
shock, renal failure)
---------------------------------------------------------------------
252. Intrebarea nr. 252: I54 Punctajul: 10CM. List the three classes of sudden cardiac death after
Hinkle:
a) [x] Sudden arrhythmogenic death
b) [ ] The occurrence of the ventricular ectopies
c) [x] Sudden death with circulatory failure
d) [x] Sudden death without stating the cause
e) [ ] Installation of cardiac arrest
---------------------------------------------------------------------
253. Intrebarea nr. 253: I55 Punctajul: 10CM. What pathological changes caused by ischemic heart
disease can be identified in patients with sudden cardiac death:
a) [x] Scar zones
b) [x] Lef ventricular hipertrophy
c) [x] Cracked aterom plaques
d) [ ] Cord structurally normal
e) [x] Occlusive thrombus
---------------------------------------------------------------------
254. Intrebarea nr. 254: I56 Punctajul: 10CM. The prodromal symptoms of sudden cardiac death
are:
a) [x] Chest pain
b) [x] Dyspnea
c) [x] Fatigue
d) [x] Palpitations
e) [x] Syncope
---------------------------------------------------------------------
255. Intrebarea nr. 255: I57 Punctajul: 10CM. Which statement is correct for the final event in the
onset of sudden cardiac death:
Page 48
48
a) [x] Installing of an acute ischemic episode
b) [x] Slow changes of the clinical status
c) [x] Dynamic changes in the electrical activity of the heart (growth of the cardiac fregvence, the
occurrence of the ventricular ectopies)
d) [x] The occurrence of malignant ventricular arrhythmias
e) [x] The installation of the cardiac arrest
---------------------------------------------------------------------
256. Intrebarea nr. 256: I58 Punctajul: 10CM. Cardiac arrest is characterized by the following
signs:
a) [x] Sudden stop of the pump function that quickly leads to death
b) [x] Loss of consciousness due to reduced cerebral flow
c) [x] Loss of effective circulation
d) [x] Hypotension
e) [x] Presyncope
---------------------------------------------------------------------
257. Intrebarea nr. 257: I59 Punctajul: 10CM. In which interval of time the irreversible brain
damages occur:
a) [x] After 4-6 minutes from the stopping of the cerebral circulation in the absence of any
intervention
b) [x] Approximately 8 minutes if it is followed by the application of basal measures for the
support of life
c) [x] About 16 min if advanced resuscitation measures are applied according to the protocol
d) [ ] After 20 minutes from the stop of the cerebral circulation in the absence of any
intervention
e) [ ] Approximately 20 minutes if it is followed by the application of basal measures for the
support of life
---------------------------------------------------------------------
258. Intrebarea nr. 258: I60 Punctajul: 10CM. List the characteristic clinical signs of sudden
cardiac death:
a) [x] Gradual breathing stop- "mirror sign"
b) [x] Absence of pulse on large vessels (carotid)
c) [x] Mydriasis (2-3 minutes)
Page 49
49
d) [x] Loss of consciousness
e) [ ] Dyspnea
---------------------------------------------------------------------
259. Intrebarea nr. 259: I61 Punctajul: 10CM. Causes of the sudden cardiac death in children are:
a) [x] Idiopathic ventricular fibrillation
b) [x] Congenital QT syndrome
c) [ ] Bleeding
d) [x] Myocarditis
e) [ ] Asthma access
---------------------------------------------------------------------
260. Intrebarea nr. 260: I62 Punctajul: 10CM. Non-cardiac causes of sudden death in children are:
a) [ ] Idiopathic ventricular fibrillation
b) [ ] Congenital QT syndrome
c) [x] Bleeding
d) [x] Poisoning
e) [x] Asthma access
---------------------------------------------------------------------
261. Intrebarea nr. 261: I63 Punctajul: 10CM. Note the non-invasive methods for the assessment of
patients with a risk of sudden cardiac death.
a) [ ] Electrophysiological tests
b) [x] EcoCG-Doppler
c) [x] ECG
d) [x] CT heart
e) [ ] Cardiac catheterization
---------------------------------------------------------------------
262. Intrebarea nr. 262: I64 Punctajul: 10CM. Write the invasive methods for the assessment of
patients with a risk of sudden cardiac death
a) [x] Electrophysiological tests
b) [ ] EcoCG-Doppler
c) [x] Coronary angiography
Page 50
50
d) [x] Scheduled stimulation
e) [x] Cardiac catheterization
---------------------------------------------------------------------
263. Intrebarea nr. 263: I65 Punctajul: 10CM What changes can record the surface
electrocardiogram in patients with increased risk of sudden cardiac death?
a) [x] Ischemic changes
b) [x] Left ventricular hypertrophy
c) [x] Long QT Syndrome
d) [x] Brugada syndrome
e) [x] Changes associated with electrolytes serum abnormalities
---------------------------------------------------------------------
264. Intrebarea nr. 264: I66 Punctajul: 10CM. List the relevant datas detected by Eco-CG Doppler
in patients with high risk of sudden cardiac death:
a) [x] Ejection fraction <30-35%
b) [x] After myocardial sequelea
c) [ ] T wave alternation
d) [x] Valvulopathies
e) [x] Congenital diseases
---------------------------------------------------------------------
265. Intrebarea nr. 265: I67 Punctajul: 10CM. In which cases is useful Holter ECG monitoring in
patients with proven risk of sudden cardiac death?
a) [x] The evaluation of ventricular tachyarrhythmias
b) [ ] Impaired left ventricular function
c) [ ] An abnormal blood pressure response during exercise may identify patients with
hypertrophic cardiomyopathy
d) [x] The assessment of ventricular bradyarrhythmias
e) [ ] Syncope
---------------------------------------------------------------------
266. Intrebarea nr. 266: I68 Punctajul: 10CM. In which cases holter -ECG test is useful for patients
with a high risk for sudden cardiac death?
a) [x] The evaluation of ventricular tachyarrhythmias
b) [ ] Impaired left ventricular function
Page 51
51
c) [ ] An abnormal blood pressure response during exercise may identify patients with
hypertrophic cardiomyopathy
d) [x] The assessment of ventricular bradyarrhythmias
e) [ ] Syncopes
---------------------------------------------------------------------
267. Intrebarea nr. 267: I69 Punctajul: 10CM. In which cases ECG effort test is useful for the
patients with a high risk of a sudden cardiac death?
a) [ ] In the evaluation of the ventricular tachyarrhythmias
b) [ ] Left ventricular function alteration
c) [x] An abnormal response of the blood pressure during the exercises may identify patients with
hypertrophic cardiomyopathy
d) [ ] In the assessment of ventricular bradyarrhythmias
e) [x] Identify the catecholaminergic polymorphic ventricular tachycardia
---------------------------------------------------------------------
268. Intrebarea nr. 268: I70 Punctajul: 10CM. What investigation will do the survivors of the
sudden cardiac death?
a) [x] ECG
b) [x] EcoCG-Doppler
c) [x] Coronary angiography
d) [x] ECG test effort
e) [x] Bioassay (hypokalemia, metabolic acidosis, increased myocardial necrosis enzymes)
---------------------------------------------------------------------
269. Intrebarea nr. 269: I71 Punctajul: 10CM. Electrophysiological stimulation is performed in
patients with:
a) [x] Ischemic heart disease
b) [x] Cardiomyopathy
c) [x] Ventricular tachycardia
d) [x] Having survived after sudden death
e) [x] Syncope
---------------------------------------------------------------------
270. Intrebarea nr. 270: I72 Punctajul: 10CM. Which statements are correct for cardiac
resuscitation?
a) [x] Provides the basal life support (BSL-basic life support)
Page 52
52
b) [x] Provides advanced life support (ALS - Advanced Life Support)
c) [x] Includes the use of an automatic external defibrillator
d) [x] The beginning of the cardiopulmonary resuscitation techniques
e) [x] Resuscitation should be initiated quickly
---------------------------------------------------------------------
271. Intrebarea nr. 271: I73 Punctajul: 10CM. Basal life support (BLS) includes:
a) [x] Check of the victim's consciousness
b) [x] Theemergency service telephone
c) [x] The opening of the airways, checking respiration
d) [x] Checking the pulse (only for the medical staff)
e) [x] Cardiac arrest <5 minutes with witnesses, automatic external defibrillator available
---------------------------------------------------------------------
272. Intrebarea nr. 272: I74 Punctajul: 10CM. Which statements are correct for external cardiac
massage?
a) [x] Effective compressions supported (no intermission)
b) [x] Complete decompressions
c) [ ] Compressions are performed with a frequency of 50/min
d) [x] Compressions are performed with a frequency of 100/min
e) [x] Compressions in the lower half of the sternum, to depress the sternum with 4-5 cm
---------------------------------------------------------------------
273. Intrebarea nr. 273: I75 Punctajul: 10CM: Advanced life support (ALS) includes:
a) [x] Cardiopulmonary resuscitation (cycles of 30 compressions: 2 ventilations or 100
compressions / min and 8-10 ventilations / min)
b) [x] The attach of a defibrillator
c) [ ] Administration of vasopressors(adrenaline, vasopressin, before / after shock)
d) [x] Administration of antiarrhythmics:Amiodaromă, lidocaine, Mg sulfate (in torsades of the
pointes)
e) [x] It is possible endotracheal administration
---------------------------------------------------------------------
274. Intrebarea nr. 274: I76 Punctajul: 10CM. For which situations is the implantable defibrillator
useful?
a) [x] Resuscitated cardiac arrest
Page 53
53
b) [x] Sustained ventricular tachycardia (TVS)
c) [x] Structural heart disease and spontaneous TVS
d) [x] Dysfunction of the left ventricle and significant left unexplained syncope
e) [x] Brugada syndrome
---------------------------------------------------------------------
275. Intrebarea nr. 275: I77 Punctajul: 10CM. Nonpharmacological primary prevention of sudden
cardiac death provides:
a) [x] Change of the lifestyle
b) [x] The rigorous control of risk factors for atherosclerosis
c) [x] The reduction of exercises
d) [ ] Administration of angiotensin converting enzyme inhibitors
e) [ ] Administration of statins and beta-blockers
---------------------------------------------------------------------
276. Intrebarea nr. 276: I78 Punctajul: 10CM.Pharmacological primary prevention of sudden
cardiac death states:
a) [x] Administration of angiotensin converting enzyme inhibitors
b) [x] Administration of statins
c) [ ] Administration of antiarrhythmic drugs
d) [x] Administration of beta-blockers
e) [x] Administration of aldosterone receptor blockers
---------------------------------------------------------------------
277. Intrebarea nr. 277: I79 Punctajul: 10CM. Cardiac causes of sudden death in children are:
a) [x] Idiopathic ventricular fibrillation
b) [x] Congenital QT syndrome
c) [ ] Bleeding
d) [ ] Poisoning
e) [ ] Asthma access
---------------------------------------------------------------------
278. Intrebarea nr. 278: I80 Punctajul: 10CM. List the relevant datas detected by Eco-CG Doppler
in patients with high risk of sudden cardiac death:
a) [ ] Ejection fraction >30-35%
b) [x] After myocardial sequelea
Page 54
54
c) [ ] T wave alternatio
d) [x] Valvulopathies
e) [x] Congenital diseases
---------------------------------------------------------------------
279. Intrebarea nr. 279: I81 Punctajul: 10CM. In which cases is not useful Holter ECG monitoring
in patients with proven risk of sudden cardiac death?
a) [ ] The evaluation of ventricular tachyarrhythmias
b) [x] Impaired left ventricular function
c) [x] An abnormal blood pressure response during exercise may identify patients with
hypertrophic cardiomyopathy
d) [ ] The assessment of ventricular bradyarrhythmias
e) [x] Syncope
---------------------------------------------------------------------
280. Intrebarea nr. 280: I82 Punctajul: 10CM. In which cases ECG test is not useful for patients
with a high risk for sudden cardiac death?
a) [x] The evaluation of ventricular tachyarrhythmias
b) [x] Impaired left ventricular function
c) [x] An abnormal blood pressure response during exercise may identify patients with
hypertrophic cardiomyopathy
d) [ ] The assessment of ventricular bradyarrhythmias
e) [ ] Syncopes
---------------------------------------------------------------------
281. Intrebarea nr. 281: I83 Punctajul: 10CM. Nonpharmacological primary prevention of sudden
cardiac death doesn't provides:
a) [ ] Change of the lifestyle
b) [ ] The rigorous control of risk factors for atherosclerosis
c) [ ] The reduction of exercises
d) [x] Administration of angiotensin converting enzyme inhibitors
e) [x] Administration of statins and beta-blockers
---------------------------------------------------------------------
282. Intrebarea nr. 282: I84 Punctajul: 10CM.Pharmacological primary prevention of sudden
cardiac death states:
a) [x] Administration of angiotensin converting enzyme inhibitors
Page 55
55
b) [x] Administration of statins
c) [x] Administration of beta-blockers
d) [ ] Administration of antiarrhythmic drugs
e) [x] Administration of aldosterone receptor blockers
---------------------------------------------------------------------
283. Intrebarea nr. 283: I85 Punctajul: 10CS. What type of cardiomyopathy develops in connective
tissue disease?
a) [ ] Ischemic Cardiomyopathy
b) [ ] Valvular cardiomyopathy
c) [ ] Hypertensive cardiomyopathy
d) [x] Inflammatory Cardiomyopathy
e) [ ] Hypertrophic Cardiomyopathy
---------------------------------------------------------------------
284. Intrebarea nr. 284: I86 Punctajul: 10CS.To what large group of cardiomyopathys does the
inflammatory cardiomyopathy belongs?
a) [ ] Dilated Cardiomyopathy
b) [ ] Hypertrophic Cardiomyopathy
c) [ ] Restrictive cardiomyopathy
d) [ ] Arrhythmogenic right ventricular cardiomyopathy
e) [x] Nonclassified cardiomyopathies
---------------------------------------------------------------------
285. Intrebarea nr. 285: I87 Punctajul: 10CS. The cardiomyopathy triggers are those listed, except:
a) [ ] Infections
b) [ ] Smoking
c) [x] Cardiac asthma
d) [ ] Hereditary factors
e) [ ] Alcohol ---------------------------------------------------------------------
286. Intrebarea nr. 286: I88 Punctajul: 10CS. Dilated cardiomyopathy is characterized by the
following, except:
a) [ ] Expansion of heart cavities
b) [ ] Decrease of the contractility (ejection fraction decrease)
Page 56
56
c) [x] The install of a heart failure
d) [ ] The occurrence of arrhythmias
e) [ ] The emergence of scar areas
---------------------------------------------------------------------
287. Intrebarea nr. 287: I89 Punctajul: 10CS. The characteristics of the dilated cardiomyopathy are
the following statements ,except:
a) [ ] Occurs at any age
b) [ ] Prevalence in males
c) [ ] In children prevails in boys
d) [ ] At 50% ,the etiology is not identified
e) [x] Prevalence to the woman
---------------------------------------------------------------------
288. Intrebarea nr. 288: I91 Punctajul: 10CM The cardiomyopathy triggers are those listed:
a) [x] Infections
b) [x] Smoking
c) [ ] Cardiac asthma
d) [x] Hereditary factors
e) [x] Alcohol
---------------------------------------------------------------------
289. Intrebarea nr. 289: I92 Punctajul: 10CM. Dilated cardiomyopathy is characterized by the
following:
a) [x] Expansion of heart cavities
b) [x] Decrease of the contractility (ejection fraction decrease)
c) [ ] The install of a heart failure
d) [x] The occurrence of arrhythmias
e) [x] The emergence of scar areas
---------------------------------------------------------------------
290. Intrebarea nr. 290: I93 Punctajul: 10CM. Select the possible causes of dilated cadiomiopathy:
a) [x] Genetic Mutations
b) [ ] Abuse of coffee
Page 57
57
c) [x] Alcohol Abuse
d) [x] Viral infections
e) [x] The action of toxins (mercury, lithium, lead)
---------------------------------------------------------------------
291. Intrebarea nr. 291: I94 Punctajul: 10CM. Mention the forms of dilated cardiomyopathy:
a) [x] Primary
b) [x] Secondary
c) [x] Family
d) [x] Non-Family
e) [ ] Tertiary
---------------------------------------------------------------------
292. Intrebarea nr. 292: I95 Punctajul: 10CM. Select the possible causes of dilated cadiomiopathy:
a) [x] Genetic Mutations
b) [x] Viral infections
c) [x] Alcohol Abuse
d) [ ] Abuse of coffee
e) [x] The action of toxins (mercury, lithium, lead)
---------------------------------------------------------------------
293. Intrebarea nr. 293: I96 Punctajul: 10CM. Mentions the morphofunctional changes in the
dilated cardiomyopathy:
a) [x] Dilation of all the cardiac cavities
b) [ ] Expansion of the isolated left ventricle
c) [x] Reduced ejection fraction
d) [ ] Isolated right ventricular dilatation
e) [x] Subendocardial interstitial fibrosis
---------------------------------------------------------------------
294. Intrebarea nr. 294: I97 Punctajul: 10CM. The common symptoms in dilated cardiomyopathy
are:
a) [x] Dyspnea accompanied by edema, fatigue
b) [x] Chest pain
Page 58
58
c) [x] Abdominal discomfort
d) [x] Anorexia
e) [x] Cerebrovascular accident ---------------------------------------------------------------------
295. Intrebarea nr. 295: I98 Punctajul: 10CM. What data reveals ECG study in patients with dilated
cardiomyopathy?
a) [x] VS myocardial hypertrophy ,sometimes VD
b) [x] Atrial fibrillation
c) [ ] Interventricular septal hypertrophy
d) [x] Extrasystoles
e) [x] Sinus rhythm
---------------------------------------------------------------------
296. Intrebarea nr. 296: I99 Punctajul: 10CM. What radiological signs can contribute to the
diagnosis of dilated cadiomyopathy?
a) [ ] Pulmonary opacity
b) [x] Cardiomegaly
c) [x] Venous stasis in the lungs
d) [x] Azygos vein dilation
e) [x] Lack of the atherosclerosis
---------------------------------------------------------------------
297. Intrebarea nr. 297: I100 Punctajul: 10CM. What changes records the echocardiography in
dilated cardiomyopathy?
a) [x] Expansion of cardiac chambers
b) [ ] Expansion of isolated left ventricular
c) [x] Decrease of ejection fraction
d) [ ] Interventricular septal hypertrophy
e) [x] Detection of the parietal thrombus
---------------------------------------------------------------------
298. Intrebarea nr. 298: I101 Punctajul: 10CM.Indicate the second step investigations in the
diagnosis of dilated cardiomyopathy:
a) [x] Computered tomography
b) [x] Review with radionuclides
Page 59
59
c) [x] Exercise testing
d) [x] Magnetic Resonance
e) [x] Myocardial Biopsy
---------------------------------------------------------------------
299. Intrebarea nr. 299: I1 Punctajul: 10CM Note the name of the idiopathic cardiomyopathy:
a) [x] arrhythmogenic right ventricular cardiomyopathy
b) [x] dilated
c) [x] hypertrophic
d) [x] restrictive
e) [ ] alcoholic
---------------------------------------------------------------------
300. Intrebarea nr. 300: I2 Punctajul: 10CM Dilated cardiomyopathy is characterized by:
a) [x] The drop ejection fraction expressed
b) [x] Dilatation of all cardiac compartments
c) [x] Worsening systole
d) [x] Cardiac decompensation
e) [ ] Increased peripheral resistance
---------------------------------------------------------------------
301. Intrebarea nr. 301: I3 Punctajul: 10CM Propose the clinical characteristic symptoms of
patients with dilated cardiomyopathy:
a) [x] dyspnea
b) [x] palpitations
c) [x] fatigue
d) [x] peripheral edema
e) [ ] epistaxis
---------------------------------------------------------------------
302. Intrebarea nr. 302: I4 Punctajul: 10CM Mention the specific echocardiographic changes in
patients with dilated cardiomyopathy:
a) [x] Dilatation of all cardiac cavities
b) [x] Decrease considerable fraction effect
c) [ ] Increase ejection fraction
d) [ ] Isolated right ventricular dilatation
e) [ ] Hypertrophy of the interventricular septum
---------------------------------------------------------------------
303. Intrebarea nr. 303: I5 Punctajul: 10CM Enumerate the characteristics of complains that can
present the patients with hypertrophic cardiomyopathy:
a) [x] bouts of angina pectoris
b) [x] syncopal states
c) [ ] Arterial Hipertension
d) [ ] Bradycardia
e) [ ] peripheral resistance
---------------------------------------------------------------------
304. Intrebarea nr. 304: I6 Punctajul: 10CM Indicate the characteristics of echocardiographic
Page 60
60
changes in hypertrophic cardiomyopathy:
a) [x] moderate hypertrophy of left ventricular posterior wall, which is less than 5 mm than the
thickness of the interventricular septum
b) [ ] left atrial dilatation
c) [ ] increase of ejection fraction
d) [ ] isolated right ventricular dilatation
e) [x] hypertrophy of the interventricular septum
---------------------------------------------------------------------
305. Intrebarea nr. 305: I7 Punctajul: 10CM Mark the signs to restrictive cardiomyopathy:
a) [x] marked thickening, diffuse of parietal endocardial LV sometimes RV
b) [ ] LV myocardial hypertrophy
c) [ ] Development of cardiomegaly
d) [ ] pinch (thin)of ventricular walls
e) [x] worsening of systola and diastola
---------------------------------------------------------------------
306. Intrebarea nr. 306: I8 Punctajul: 10CM Arrhythmogenic cardiomyopathy is manifested by:
a) [ ] marked thickening, diffuse parietal endocardial LV sometimes RV
b) [ ] LV myocardial hypertrophy
c) [x] frequent ventricular arrhythmias
d) [x] pinch (thin) ventricular walls
e) [ ] spongy myocardium
---------------------------------------------------------------------
307. Intrebarea nr. 307: I9 Punctajul: 10CM Mention wich patients with cardiomyopathy
requiring cardiac defibrillator:
a) [x] Hypertrophic Cardiomyopathy
b) [ ] Alcoholic Cardiomyopathy
c) [ ] Dilated Cardiomyopathy
d) [ ] Restrictive cardiomyopathy
e) [x] Arrhythmogenic cardiomyopathy
---------------------------------------------------------------------
308. Intrebarea nr. 308: I10 Punctajul: 10CM Name the changes characteristic of patients with
dilated cardiomyopathy
a) [x] Decreased left ventricular ejection fraction
b) [ ] Increase of cardiac output
c) [ ] Hypertrophy of the interventricular septum
d) [x] Increase of intracavitary pressure
e) [ ] Increase of ejection fraction
---------------------------------------------------------------------
309. Intrebarea nr. 309: I11 Punctajul: 10CS Name the most informative method in the diagnosis of
hypertrophic cardiomyopathy:
a) [ ] Myocardial biopsy
b) [x] Echocardiography
c) [ ] Phonocardiography
d) [ ] Electrocardiography
e) [ ] Monitoring - ECG
---------------------------------------------------------------------
Page 61
61
310. Intrebarea nr. 310: I12 Punctajul: 10CS What medications do you manage to patients with
dilated cardiomyopathy:
a) [ ] Diuretics
b) [ ] ACE inhibitors
c) [ ] Antiarrhythmics
d) [ ] Anticoagulants
e) [x] Antipyretics
---------------------------------------------------------------------
311. Intrebarea nr. 311: I13 Punctajul: 10CS Mention the most severe form of hypertrophic
cardiomyopathy
a) [x] obstructive
b) [ ] unobtrusive
c) [ ] apical
d) [ ] restrictive
e) [ ] dilatative
---------------------------------------------------------------------
312. Intrebarea nr. 312: I14 Punctajul: 10CS Indicate the severe complication in patients with
hypertrophic cardiomyopathy with outflow tract obstruction:
a) [x] Ventricular tachycardia
b) [ ] Atrial fibrillation
c) [ ] Syncopal states
d) [ ] Atrial flutter
e) [ ] Anasarca
---------------------------------------------------------------------
313. Intrebarea nr. 313: I15 Punctajul: 10CS Indicate the characteristic ECG changes in patients
with dilated cardiomyopathy?
a) [ ] Complete atrioventricular block
b) [ ] Complete sinoatrial block B
c) [ ] Atrial fibrillation
d) [x] Q-waves in leads unexplained chest
e) [ ] Low Voltage
---------------------------------------------------------------------
314. Intrebarea nr. 314: I16 Punctajul: 10CM Name the arrhythmias characteristic of patients with
hypertrophic cardiomyopathy
a) [x] Ventricular fibrilation
b) [x] Ventricular flutter
c) [ ] Atrial fibrillation
d) [x] Ventricular tachycardia
e) [ ] Low Voltage
---------------------------------------------------------------------
315. Intrebarea nr. 315: I17 Punctajul: 10CM Treatment of patients with hypertrophic obstructive
cardiomyopathy include:
a) [ ] Cardiac glycosides
b) [x] Beta blockers
c) [ ] Nitrate
d) [x] Diuretics
Page 62
62
e) [x] Antiarrhythmics
---------------------------------------------------------------------
316. Intrebarea nr. 316: I18 Punctajul: 10CS What surgical method is not used in patients with
significant obstructive hypertrophic cardiomyopathy:
a) [ ] Partial Mioectomia
b) [ ] Septal ablation with alcohol
c) [ ] Embolization of first septal
d) [ ] Implantation of defibrillator - cardioverter
e) [x] Total Mioectomie
---------------------------------------------------------------------
317. Intrebarea nr. 317: I19 Punctajul: 10CM Indicate clinical signs of patients with restrictive
cardiomyopathy:
a) [x] Inspiratory Dyspnea
b) [x] Palpitations
c) [x] Fatigue
d) [ ] Headache
e) [ ] Vertigo
---------------------------------------------------------------------
318. Intrebarea nr. 318: I20 Punctajul: 10CM Name the factors that can trigger the
cardiomyopathy:
a) [x] stress
b) [x] exercise
c) [x] viral infections
d) [ ] smoking
e) [ ] balanced diet ---------------------------------------------------------------------
319. Intrebarea nr. 319: I1 Punctajul: 10CS About 83% of the population affected by coronary heart
disease is aged over:
a) [ ] 45 years
b) [ ] 35 years
c) [x] 65 years
d) [ ] 85 years
e) [ ] 70 years
---------------------------------------------------------------------
320. Intrebarea nr. 320: I2 Punctajul: 10CS Which of the following is the correct definition of the body
mass index:
a) [ ] Circumference measured from the umbilicus and halfway between the costal margin and iliac crest
b) [x] The ratio of weight (in kg) and the square of the heigh (m) c) [ ] Report of the 2 circumference reflects the type of obesity
d) [ ] LDL cholesterol and HDL cholesterol ratio
e) [ ] Report of 3 circumferences reflects the type of obesity
---------------------------------------------------------------------
321. Intrebarea nr. 321: I3 Punctajul: 10CS The obesity paradox is defined as:
a) [ ] Represents a growing problem in the developed world
b) [ ] Is a major risk factor for atherosclerotic disease
c) [x] A better short or long-term prognosis for overweight or obese patients
d) [ ] Is a minor risk factor for atherosclerotic disease
Page 63
63
e) [ ] An unfavorable short or long-term prognosis for overweight or obese patients ---------------------------------------------------------------------
322. Intrebarea nr. 322: I4 Punctajul: 10CS Framingham score is calculated by:
a) [x] Basis of equations that take into account gender, age, total cholesterol, HDL cholesterol, smoking
status and systolic, assigning a number of points depending on the presence and magnitude of each factor
b) [ ] Deaths from non coronary atherosclerosis territories are taken into account
c) [ ] The mean ages adapted to the changing risk with age is steeper
d) [ ] Related to cardiovascular mortality and not total cardiovascular events
e) [ ] It is available in two versions- one for low-risk regions (Belgium, France, Greece, Italy,
Luxembourg, Spain, Switzerland and Portugal) and another for those at high risk, where falling and our
country, together with other countries European were not mentioned in the previous list ---------------------------------------------------------------------
323. Intrebarea nr. 323: I5 Punctajul: 10CS Which of the following is the correct definition of
abdominal circumference:
a) [x] Circumference measured from the umbilicus and halfway between the costal margin and iliac crest
b) [ ] The ratio of weight (in kg) and the square of the heigh (m) (g / h squared)
c) [ ] Report of the two circumference reflects the type of obesity
d) [ ] LDL cholesterol and HDL cholesterol ratio
e) [ ] Report of three circumferences reflects the type of obesity
---------------------------------------------------------------------
324. Intrebarea nr. 324: I6 Punctajul: 10CS Which of the following is the correct definition for hip
circumference ratio in waist circumference (waist to hip ratio)
a) [ ] Circumference measured from the umbilicus and halfway between the costal margin and iliac crest
b) [ ] The ratio of weight (in kg) and the square of the heigh (m) (g / h squared)
c) [x] Report of the two circumference reflects the type of obesity
d) [ ] LDL cholesterol and HDL cholesterol ratio
e) [ ] Report of three circumferences reflects the type of obesity
---------------------------------------------------------------------
325. Intrebarea nr. 325: I7 Punctajul: 10CS. Which of the following is the correct definition of
hyperhomocysteinaemia:
a) [ ] In vitro and in vivo studies that have shown to promote atherogenesis and thrombogenesis,
representing a moderately independent favorable cardiovascular risk factor
b) [ ] Genetic defects leading to procoagulant potential are known as thrombophilia
c) [x] Remains the main cause of genetic hyperhomocysteinaemia. The main changes are found in
the population type MTHFR C677T gene mutation A1298C respectively
d) [ ] Hyperhomocysteinaemia cause is not known
e) [ ] Remains the main cause of genetic hyperhomocysteinaemia. The main changes occur in the
population of type C123 MTR gene mutations
---------------------------------------------------------------------
326. Intrebarea nr. 326: I8 Punctajul: 10CM What are the cardiovascular risk factors listed below:
a) [x] Major
b) [ ] Minors
c) [x] Classics
d) [x] Modifiable
e) [x] Unchangeable
---------------------------------------------------------------------
327. Intrebarea nr. 327: I9 Punctajul: 10CM Tick the cardiovascular risk factors that are considered
modifiable:
Page 64
64
a) [x] Obesity
b) [ ] Age
c) [x] High blood pressure
d) [ ] Sex
e) [x] Smoking
---------------------------------------------------------------------
328. Intrebarea nr. 328: I10 Punctajul: 10CM Major risk factors were defined by WHO through:
a) [x] High prevalence in the population
b) [ ] Low prevalence in the population
c) [x] Independent impact on the risk of coronary heart disease or stroke
d) [x] Treatment or control lowers the risk
e) [ ] Treatment or control risk-accelerating
---------------------------------------------------------------------
329. Intrebarea nr. 329: I12 Punctajul: 10CM Tick cardiovascular risk factors that are considered
unchangeable:
a) [ ] Obesity
b) [x] Age
c) [ ] High blood pressure
d) [x] Sex
e) [x] Heredity
---------------------------------------------------------------------
330. Intrebarea nr. 330: I13 Punctajul: 10CM Obesity is a major cardiovascular risk factor with
increasing prevalence in developed countries, mainly due to:
a) [x] Environmental and social factors
b) [x] Dietary habits
c) [x] Sedentary life
d) [ ] Alcoholism
e) [ ] High blood pressure
---------------------------------------------------------------------
331. Intrebarea nr. 331: I14 Punctajul: 10CM Score SCORE unlike Framingham score:
a) [x] Is related to cardiovascular mortality and not total cardiovascular events
b) [x] Are taken into account deaths from non-coronary atherosclerosis territories
c) [x] The school is adjusted to average of ages, to which risks change with more abrupt age
d) [x] There are separate scores for European countries with high risk, respective to low risk, or
where complete data on mortality exists
e) [ ] Is related to cardiovascular mortality and total cardiovascular events
---------------------------------------------------------------------
332. Intrebarea nr. 332: I15 Punctajul: 10CM Dyslipidemia:
a) [x] Represents among factors with great prevalence and susceptibility of being modified
b) [x] Includes a number of disorders of lipid metabolism potentially atherosclerotic phenomena
of induction and maintenance
c) [ ] Is related to cardiovascular mortality and total cardiovascular events
d) [ ] A better short or long-term prognosis for overweight or obese patients
e) [ ] It is one of the factors with low prevalence and susceptibility of being modified
---------------------------------------------------------------------
333. Intrebarea nr. 333: I16 Punctajul: 10CM What three components must be included in a
Page 65
65
comprehensive action for the prevention of cardiovascular risk factors according to the World
Health Organization (WHO):
a) [ ] Primary prevention
b) [x] Population Strategy
c) [x] Strategy for high risk populations
d) [x] Secondary prevention
e) [ ] Strategy for low risk populations
---------------------------------------------------------------------
334. Intrebarea nr. 334: I17 Punctajul: 10CM Individuals with increased cardiovascular risk are
those with:
a) [x] Multiple risk factors, giving a risk score ≥ 5%
b) [x] Marked increased level of a single risk factor, such as BP ≥ 180/110 mmHg or persistent
BP ≥ 160/110mmHg, these values should be treated, regardless of the presence of other risk
factors
c) [x] Total cholesterol ≥ 8 mmol / L (320mg/dL), LDL-cholesterol ≥ 6 mmol / L (240mg/dL)
d) [x] Diabetes (relative risk is 5 women and 3 men)
e) [ ] Multiple risk factors, giving a risk score ≥ 20%
---------------------------------------------------------------------
335. Intrebarea nr. 335: I18 Punctajul: 10CM Which of the following are functions of the grid
SCORE:
a) [x] Highlight the risk of fatal cardiovascular event within 10 years without additional
calculations
b) [x] Estimates relative risk by comparing a cell (grid square) with any other, in the same age
group
c) [x] Assessment of the impact of improvements to risk factors (novel subject moves from one
risk category to another by giving up to smoking, lowering total cholesterol etc.)
d) [ ] Estimation of absolute risk by comparing a cell (grid square) with any other, in the same age
group
e) [x] Highlights the effect of the action of a risk factor over time (increasing risk with increased
age, younger ages are generally at lower risk) ---------------------------------------------------------------------
336. Intrebarea nr. 336: I19 Punctajul: 10CM Tick the haemostatic factors which are correlated
with increased cardiovascular risks:
a) [x] Activated factor VII
b) [x] Plasminogen activator inhibitor-1
c) [ ] Activated factor V
d) [x] Tissue plasminogen activator (tPA)
e) [x] von Willebrand factor (which is also a marker of endothelial dysfunction)
---------------------------------------------------------------------
337. Intrebarea nr. 337: I20 Punctajul: 10CM Which of the following lifestyle changes reduce
cardiovascular risks in patients with hypertension:
a) [ ] High sodium diet, low weight, moderate consumption of ethyl alcohols
b) [x] Low sodium diet, low weight, moderate consumption of ethyl alcohols
c) [x] Pharmacological measures should be added to obtain normal BP values
d) [ ] Pharmacological measures to achieve normal BP values should not be added
e) [x] An optimal control of BP values decreases significantly the risk of recurrence of a stroke, or
Page 66
66
cardiovascular death after a heart attack ---------------------------------------------------------------------
338. Intrebarea nr. 338: I21 Punctajul: 10CM Mechanisms which increase cardiovascular risk in
smoking are:
a) [x] Increased total cholesterol and lower HDL cholesterol
b) [x] Activation of platelets and leukocytes, increased circular fibrinogen
c) [x] Endothelial dysfunction by promoting vulnerable plaques fissures, increased heart rate and
blood pressure
d) [x] Arterial vasoconstriction (including coronary spasm), effects of worsening myocardial
ischemia due to carbon monoxide
e) [ ] Decrease of circular fibrinogen
---------------------------------------------------------------------
339. Intrebarea nr. 339: I1 Punctajul: 10CS Choose which of the markers listed below refers to the
injury of myocytes:
a) [ ] C-reactive protein, tumor necrosis factor alpha, interleukins, Fas (APO1)
b) [ ] Norepinephrine, epinephrine, angiotensin II, renin, aldosterone, arginine vasopressin,
endothelin
c) [ ] B- natriuretic peptide (BNP), NTpro-BNP, proadrenomedulina
d) [ ] Oxidized low-density lipoproteins, myeloperoxidases, malondialdehyde, urinary biopirines
e) [x] Troponins I and T, creatine kinase MB, light chain myosin kinase, cardiac fatty acids
associated with proteins
---------------------------------------------------------------------
340. Intrebarea nr. 340: I2 Punctajul: 10CS Choose which of the markers listed below refers to
those of inflammation:
a) [x] C-reactive protein, tumor necrosis factor alpha, interleukins, Fas (APO1)
b) [ ] Norepinephrine, epinephrine, angiotensin II, renin, aldosterone, arginine vasopressin,
endothelin
c) [ ] B- natriuretic peptide (BNP), NTpro-BNP, proadrenomedulina
d) [ ] Oxidized low-density lipoproteins, myeloperoxidases, malondialdehyde, urinary biopirines
e) [ ] Troponins I and T, creatine kinase MB, light chain myosin kinase, cardiac fatty acids
associated with proteins
---------------------------------------------------------------------
341. Intrebarea nr. 341: I3 Punctajul: 10CS Choose which of the markers listed below refers to
those of oxidative stress:
a) [ ] C-reactive protein, tumor necrosis factor alpha, interleukins, Fas (APO1)
b) [ ] Norepinephrine, epinephrine, angiotensin II, renin, aldosterone, arginine vasopressin,
endothelin
c) [ ] B- natriuretic peptide (BNP), NTpro-BNP, proadrenomedulina
d) [x] Oxidized low-density lipoproteins, myeloperoxidases, malondialdehyde, urinary biopirines
e) [ ] Troponins I and T, creatine kinase MB, light chain myosin kinase, cardiac fatty acids
associated with proteins
---------------------------------------------------------------------
342. Intrebarea nr. 342: I4 Punctajul: 10CS Choose which of the markers listed below refers to
neurohormonal ones:
a) [ ] C-reactive protein, tumor necrosis factor alpha, interleukins, Fas (APO1)
b) [x] Norepinephrine, epinephrine, angiotensin II, renin, aldosterone, arginine vasopressin,
Page 67
67
endothelin
c) [ ] B- natriuretic peptide (BNP), NTpro-BNP, proadrenomeduline
d) [ ] Oxidized low-density lipoproteins, myeloperoxidases, malondialdehyde, urinary biopirines
e) [ ] Troponins I and T, creatine kinase MB, light chain myosin kinase, cardiac fatty acids
associated with proteins
---------------------------------------------------------------------
343. Intrebarea nr. 343: I5 Punctajul: 10CS Choose which of the markers listed below refers to
the stress of myocytes:
a) [ ] C-reactive protein, tumor necrosis factor alpha, interleukins, Fas (APO1)
b) [ ] Norepinephrine, epinephrine, angiotensin II, renin, aldosterone, arginine vasopressin,
endothelin
c) [x] B- natriuretic peptide (BNP), NTpro-BNP, proadrenomedulina
d) [ ] Oxidized low-density lipoproteins, myeloperoxidases, malondialdehyde, urinary biopirines
e) [ ] Troponins I and T, creatine kinase MB, light chain myosin kinase, cardiac fatty acids
associated with proteins
---------------------------------------------------------------------
344. Intrebarea nr. 344: I7 Punctajul: 10CS Continuous ECG monitoring is:
a) [ ] Recommended for patients with sporadic symptoms or very short, able to activate the device
so as to store in its memory ECG immediately preceding symptomatic episode
b) [x] Particularly useful in symptomatic patients with syncope, which could not turn in time with
the recording device type or in patients with intermittent symptoms occurring daily or almost
daily
c) [ ] The most used method for the diagnosis and / or risk stratification of patients with stable
angina, unstable angina which was stabilized therapeutically, patients after myocardial infarction
or patients with myocardial revascularization
d) [ ] Provides information about pulmonary circulation and thoracic aorta, as well as about
possible associated lung damages
e) [ ] The most used method for the diagnosis and / or risk stratification of patients with stable
angina, unstable angina which was stabilized therapeutically, patients after myocardial infarction
or patients with myocardial revascularization
---------------------------------------------------------------------
345. Intrebarea nr. 345: I8 Punctajul: 10CS Intermittent ECG monitoring is:
a) [x] Recommended for patients with sporadic symptoms or very short, able to activate the
device so as to store in its memory ECG immediately preceding symptomatic episode
b) [ ] Particularly useful in symptomatic patients with syncope, which could not turn in time with
the recording device type or in patients with intermittent symptoms occurring daily or almost
daily
c) [ ] The most used method for the diagnosis and / or risk stratification of patients with stable
angina, unstable angina which was stabilized therapeutically, patients after myocardial infarction
or patients with myocardial revascularization
d) [ ] Provides information about pulmonary circulation and thoracic aorta, as well as about
possible associated lung damages
e) [ ] The most used method for the diagnosis and / or risk stratification of patients with stable
angina, unstable angina which was stabilized therapeutically, patients after myocardial infarction
or patients with myocardial revascularization
---------------------------------------------------------------------
Page 68
68
346. Intrebarea nr. 346: I9 Punctajul: 10CS Resting potential value of cardiomyocytes is:
a) [ ] -70mV
b) [ ] +40mV
c) [x] -90mV
d) [ ] 0mV
e) [ ] +10 mV
---------------------------------------------------------------------
347. Intrebarea nr. 347: I10 Punctajul: 10CS How many derivations are used to record standard
ECG:
a) [ ] 10 derivation
b) [x] 12 derivations
c) [ ] 6 derivations
d) [ ] 8 derivations
e) [ ] 2 derivations
---------------------------------------------------------------------
348. Intrebarea nr. 348: I11 Punctajul: 10CS The enlargement of the right atrium on radiography
determine:
a) [x] Opacity of retrosternal space
b) [ ] Bulging lower arch as more than 5.5 cm to the right of the midline
c) [ ] Previous projection of thoracic vertebral bodies
d) [ ] Opacity of subdiaphragmatic space
e) [ ] Right ventricular hypertrophy
---------------------------------------------------------------------
349. Intrebarea nr. 349: I12 Punctajul: 10CS Which statement regarding pulsed Doppler is
FALSE:
a) [x] It measures blood velocity in the direction of the ultrasound beam
b) [ ] It has a low amplitude measurable velocity
c) [ ] It measures blood velocity only in the interest zone
d) [ ] It is destinated for flows with low velocity
e) [ ] It has a spatial resolution
---------------------------------------------------------------------
350. Intrebarea nr. 350: I13 Punctajul: 10CS The main advantages of radionuclide
ventriculography over radiological ventriculography with contrast are the following, except:
a) [x] The test provides detailed information on the anatomy of the cardiac chambers and
maximum information on the structure and valvular function
b) [ ] The ability to study both ventricles simultaneously
c) [ ] Ability to take repeated measurements (before and after exercise)
d) [ ] The method provides optimum contrast between target ventricular volumes and background
e) [ ] Noninvasive nuclear procedures
---------------------------------------------------------------------
351. Intrebarea nr. 351: I14 Punctajul: 10CS The cease of the ECG exercise test is done in all
following cases, except:
a) [ ] Decrease in systolic blood pressure over 10 mm Hg from baseline
b) [x] Hiccup
c) [ ] Moderate / severe angina
d) [ ] Dizziness, ataxia or presyncope
Page 69
69
e) [ ] Cyanosis or pallor
---------------------------------------------------------------------
352. Intrebarea nr. 352: I15 Punctajul: 10CS What is the distance for taking the radiography in
posterior-anterior incidence?
a) [x] 1,5-2 m
b) [ ] 30-50 cm
c) [ ] 1 m
d) [ ] 20-25 cm
e) [ ] 2-3 m
---------------------------------------------------------------------
353. Intrebarea nr. 353: I16 Punctajul: 10CS Resting electrocardiogram is:
a) [ ] Is the most used method for the diagnosis and / or risk stratification of patients with stable
angina, unstable angina which was stabilized therapeutically, patients after myocardial infarction
or patients with myocardial revascularization
b) [x] Is a paraclinical investigation most commonly used in cardiological examination
c) [ ] To assess the heart and its cavities
d) [ ] Provides information about pulmonary circulation and thoracic aorta, as well as about
possible associated lung damages
e) [ ] Allows monitoring and treatment of heart disease
---------------------------------------------------------------------
354. Intrebarea nr. 354: I17 Punctajul: 10CS Which of the following clinical applications is not
characteristic of PET (positron emission tomography):
a) [ ] Is effectuating on patients which have hypoperfused and dysfunctional myocardial
segments
b) [ ] Metabolic imaging
c) [ ] It is used to detect microcirculation dysfunction
d) [x] Determination of coronary calcium score
e) [ ] ECG
---------------------------------------------------------------------
355. Intrebarea nr. 355: I18 Punctajul: 10CS The general diagnostic accuracy of PET's (positron
emission tomography) study is about:
a) [x] 90 %
b) [ ] 60%
c) [ ] 100%
d) [ ] 75%
e) [ ] 40%
---------------------------------------------------------------------
356. Intrebarea nr. 356: I19 Punctajul: 10CS The most used score to determine coronary calcium
score is:
a) [x] Agatston score
b) [ ] Hounsfield score
c) [ ] Mobitz score
d) [ ] Sokolow score
e) [ ] Hoffman score
---------------------------------------------------------------------
357. Intrebarea nr. 357: I20 Punctajul: 10CS What is not characteristic of balanced radionucleide
Page 70
70
ventriculography:
a) [ ] Assume the purchase of 16-24 frames in RR interval
b) [x] It records a short sequence of cardiac cycles
c) [ ] In balanced radionucleide ventriculography labeled 99mTc red blood cells are used
d) [ ] Balanced radionucleide ventriculography synchronized requires the presence of sinus
rhythm
e) [ ] Data are acquired sequentially in the memory of a proper frame
---------------------------------------------------------------------
358. Intrebarea nr. 358: I21 Punctajul: 10CS Exercise testing is done by monitoring the patient's
ECG:
a) [ ] The administration of dipyridamole
b) [ ] With tilted table
c) [x] During cycling or treadmill
d) [ ] The administration of ergometrine
e) [ ] During respiratory arrest ---------------------------------------------------------------------
359. Intrebarea nr. 359: I22 Punctajul: 10CS Intracardiac electrophysiological study is:
a) [ ] Noninvasive diagnostic method of intracardiac rhythm disorders and management of cardiac
arrhythmias
b) [x] Invasive diagnostic method of intracardiac rhythm disorders and management of cardiac
arrhythmias
c) [ ] Study of cardiac activity using 3D Eco
d) [ ] Exclusive diagnostics of atrial fibrillation and ventricular
e) [ ] Method of testing only elderly patients
---------------------------------------------------------------------
360. Intrebarea nr. 360: I23 Punctajul: 10CS What is the way of percutaneous approach of
introducing catheters into SEF (electrophysiological study) most often used?
a) [ ] Vena saphena magna
b) [x] Femoral vein
c) [ ] Abdominal aorta
d) [ ] Inferior vena cava
e) [ ] Femoral artery
---------------------------------------------------------------------
361. Intrebarea nr. 361: I24 Punctajul: 10CS Choose radiological signs of ascending aorta
increase:
a) [ ] A prominent aortic button
b) [ ] Difficult to assess
c) [x] Curved upper right arc
d) [ ] Curved arc left upper
e) [ ] Not shown to radiography
---------------------------------------------------------------------
362. Intrebarea nr. 362: I25 Punctajul: 10CS Characterized the pulmonary venous hypertensions:
a) [x] Radiographic - vessels in the upper lung fields are equal to or greater than the basal
b) [ ] Radiographic - vessels in the upper lung fields are equal to or less than the basal
c) [ ] Radiographic - vessels in the upper lung fields become equal to the basal
d) [ ] Dilatation of the pulmonary artery trunk
Page 71
71
e) [ ] Pulmonary hilum is large due to very dilated central vessels compared with peripheral ones
---------------------------------------------------------------------
363. Intrebarea nr. 363: I26 Punctajul: 10CS Which radiographic aspects are not characteristic of
interstitial edema:
a) [ ] The opaque pleural axillary or basal tape
b) [ ] Changes in heart consideration
c) [x] The inelar opacity
d) [ ] Left atrium increase
e) [ ] Alveolar transudation as nodular opacities, localized mainly at the base
---------------------------------------------------------------------
364. Intrebarea nr. 364: I27 Punctajul: 10CS The definition of markers sensitivity is understood:
a) [ ] The power to identify real negative cases
b) [x] The ability to detect true positive cases
c) [ ] Ability to identify a single disease
d) [ ] Presence of instabil marker in the body
e) [ ] The vulnerability of the marker to the action of environmental factors
---------------------------------------------------------------------
365. Intrebarea nr. 365: I28 Punctajul: 10CS The definition of specificity of a marker is
understood:
a) [ ] The ability to detect true positive cases
b) [ ] The vulnerability of the marker to the action of environmental factors
c) [ ] Ability to identify a single disease
d) [x] The power to identify real negative cases
e) [ ] Presence of instable marker in the body
---------------------------------------------------------------------
366. Intrebarea nr. 366: I29 Punctajul: 10CS The left middle arch on chest radiography is formed
by:
a) [ ] Ascending aorta
b) [x] Pulmonary trunk
c) [ ] Descending aorta
d) [ ] Left atrium
e) [ ] Left ventricle
---------------------------------------------------------------------
367. Intrebarea nr. 367: I30 Punctajul: 10CS To do ventriculography it is necessary to introduce
intracavitary a:
a) [ ] Foley Catheter
b) [x] Catheter "Pigtail"
c) [ ] Sleep probe
d) [ ] Probe Swan-Ganz
e) [ ] Judkins catheter
---------------------------------------------------------------------
368. Intrebarea nr. 368: I31 Punctajul: 10CS Tick the not frequent complications of cardiac
catheterization and angiography:
a) [ ] Hematoma at puncture site
b) [ ] Vasovagal reactions
c) [ ] Allergic reactions to contrast agents and drugs
Page 72
72
d) [ ] Inflammation or exudate at puncture site
e) [x] Trauma
---------------------------------------------------------------------
369. Intrebarea nr. 369: I32 Punctajul: 10CM Which of the given below relate to markers of
myosytes injury:
a) [x] Tropinin heart I and T, myosin - light chain kinase
b) [x] Cardiac fatty acids bound to protein
c) [x] Creatine kinase, creatine kinase MB
d) [x] Albumin modified by ischemia
e) [ ] Interleukins 1, 6 and 8
---------------------------------------------------------------------
370. Intrebarea nr. 370: I33 Punctajul: 10CM Which of the listed below refers to markers of
interstitial remodeling matrix :
a) [ ] Myosin - light chain kinase
b) [ ] C-reactive protein
c) [x] Matrix metalloproteinases
d) [x] Tissue inhibitors of metalloproteinases
e) [x] Peptide procollagen I
---------------------------------------------------------------------
371. Intrebarea nr. 371: I34 Punctajul: 10CM Which of the listed below relates to markers of
inflammation:
a) [ ] Albumin modified by ischemia
b) [x] C-reactive protein
c) [x] Tumour necrosis factor alpha
d) [x] Fas (APO-1)
e) [x] Interleukins 1, 6 and 8
---------------------------------------------------------------------
372. Intrebarea nr. 372: I35 Punctajul: 10CM Which of the listed below relates to markers of
oxidative stress:
a) [x] Oxidized low density lipoprotein
b) [x] Mielloproteases
c) [x] Melondialdehyde
d) [ ] C-reactive protein
e) [ ] Tumour necrosis factor alpha
---------------------------------------------------------------------
373. Intrebarea nr. 373: I36 Punctajul: 10CM Which of the following relates to neuroumoral
markers:
a) [x] Peptide heart natriuretics
b) [x] Renin - angiotensin-aldosterone
c) [x] Adrenergic nervous system
d) [x] Arginine vasopressin, Peptides derived from endothelium
e) [ ] Mielloproteases
---------------------------------------------------------------------
374. Intrebarea nr. 374: I37 Punctajul: 10CM ECG Interpretation provides information with
diagnostic, therapeutic and essential prognostic implications,especially in the management of
patients with:
Page 73
73
a) [x] Acute Coronary Syndrome
b) [x] Arrhythmia
c) [x] Diselectrolytemia
d) [x] Electrical anomalies with genetical substrate
e) [ ] Dilated cardiomiopathy
---------------------------------------------------------------------
375. Intrebarea nr. 375: I38 Punctajul: 10CM What are the indications carrying the standard 12
lead electrocardiogram in cardiology practice:
a) [x] Patient's treatment can cause side effects that can be detected by ECG
b) [x] Patients with pacemaker implantation, patients with stable chronic heart disease regularly
evaluate
c) [x] Evaluation of patients with increased risk of cardiovascular disease, assess response to
cardiac treatment
d) [x] Changes in the clinical or biological condition indicate cardiac dysfunction, patients> 40
years undergoing routine examinations
e) [ ] X-ray evaluation of the patient
---------------------------------------------------------------------
376. Intrebarea nr. 376: I39 Punctajul: 10CM Which of the statements listed below are correct for
left ventricular hypertrophy:
a) [ ] ST segment elevation
b) [x] Left ventricular hypertrophy is an independent prognostic parameter value
c) [x] The European Society of Cardiology recommends ECG as mandatory study investigation in
the initial assessement of all newly diagnosed hypertensive patients in risk stratification for
adverse cardiovascular events
d) [x] A large variability and significantly lower sensitivity in the ECG compared to
echocardiography in diagnosing SS especially when using voltage criteria
e) [ ] Left bundle branch block
---------------------------------------------------------------------
377. Intrebarea nr. 377: I40 Punctajul: 10CM ECG recording quality can be influenced by:
a) [x] Chronic lung disease
b) [x] Incorrect placement of electrodes
c) [x] Obesity
d) [ ] Renal involvement
e) [x] Respiratory movements
---------------------------------------------------------------------
378. Intrebarea nr. 378: I41 Punctajul: 10CM The indications of standard 12-lead
electrocardiogram is indicated for patients with:
a) [x] Pacemaker implant
b) [x] Increased risk of heart disease
c) [x] Stable chronic heart disease
d) [x] Patients aged >40 during a routine examination
e) [ ] Acute respiratory impairment ---------------------------------------------------------------------
379. Intrebarea nr. 379: I42 Punctajul: 10CM The main criteria of ECG diagnostics of left
ventricular hypertrophy used in clinical practice are included in the index of:
a) [x] Sokolow-Lyon
Page 74
74
b) [x] Cornell
c) [x] Romhilt-Estes
d) [x] Perugia
e) [ ] Mobitz
---------------------------------------------------------------------
380. Intrebarea nr. 380: I43 Punctajul: 10CM Absolute contraindications for ECG stress test are:
a) [x] Acute aortic dissection
b) [ ] Headache
c) [ ] Physical or mental disorders that prevent effort
d) [x] Myocardial infarction (within 2 days after onset)
e) [x] Acute pulmonary embolism or pulmonary infarction
---------------------------------------------------------------------
381. Intrebarea nr. 381: I44 Punctajul: 10CM Which of the following is used for imaging
perfusion:
a) [x] Technetium 99
b) [ ] Vasovist
c) [x] Thallium 201
d) [ ] TESLASCAN
e) [ ] BaSO4
---------------------------------------------------------------------
382. Intrebarea nr. 382: I45 Punctajul: 10CM In cardiology radionuclide imaging includes the
possibility of:
a) [x] Myocardial perfusion scintigram
b) [x] Radionuclide ventriculography
c) [ ] ECG Holter
d) [x] Positron emission tomography
e) [ ] Ergometry
---------------------------------------------------------------------
383. Intrebarea nr. 383: I46 Punctajul: 10CM Transesophageal echocardiography isapplied mainly
in:
a) [ ] Infective Endocarditis (diagnosis, complications)
b) [x] Detecting sources of embolism
c) [ ] Evaluation of congenital heart disease
d) [x] Evaluation of aortic prostheses
e) [x] Non infectious Endocarditis
---------------------------------------------------------------------
384. Intrebarea nr. 384: I47 Punctajul: 10CM Which of the followingin contrast agents are used in
CT examination:
a) [x] Ultravist
b) [x] OMNIPAQUE
c) [x] Visipaque
d) [ ] Technetium
e) [ ] Silicon
---------------------------------------------------------------------
385. Intrebarea nr. 385: I48 Punctajul: 10CM Tick the physiological limitations of CT
investigation:
Page 75
75
a) [x] The presence of arrhythmias
b) [x] Sinus tachycardia
c) [x] The presence of calcifications
d) [ ] The cost of the contrast
e) [x] Irradiance dose
---------------------------------------------------------------------
386. Intrebarea nr. 386: I49 Punctajul: 10CM Magnetic resonance imaging allows to diagnose:
a) [x] The location and extension of myocardial necrosis
b) [x] Myocarditis
c) [x] Cardiomyopathy
d) [x] Valvulopathy
e) [ ] Anatomy of mediastinal veins
---------------------------------------------------------------------
387. Intrebarea nr. 387: I50 Punctajul: 10CM The main indications for ambulatory ECG
monitoring:
a) [x] Patients with unexplained palpitations
b) [x] Evaluation of antiarrhythmic therapy
c) [ ] Cardiac tamponade
d) [ ] Pericardial effusion with a quantity of 2000 ml of liquid
e) [x] Patients with unexplained syncope choices
---------------------------------------------------------------------
388. Intrebarea nr. 388: I51 Punctajul: 10CM Which of the following is characteristics of arterial
pulmonary hypertension:
a) [ ] Radiography - vessels in the upper lung fields are equal to or greater than the basal
b) [ ] Radiography - vessels in the upper lung fields are equal to or less than the basal
c) [ ] Radiography - vessels in the upper lung fields become equal to the basal
d) [x] Dilatation of the pulmonary artery trunk
e) [x] Pulmonary hilum is large due to very dilated central vessels compared with peripheral
ones
---------------------------------------------------------------------
389. Intrebarea nr. 389: I52 Punctajul: 10CM Echocardiography advantages are:
a) [x] It provides accurate information about structure and function of the heart
b) [x] It is widely available
c) [x] It is easily repeatable if necessary
d) [ ] It is operator dependent
e) [x] It is cost-effective
---------------------------------------------------------------------
390. Intrebarea nr. 390: I53 Punctajul: 10CM The main methods used for routine
echocardiography are:
a) [x] Echocardiography in M
b) [ ] Transesophageal echocardiography
c) [x] 2D echocardiography (two-dimensional)
d) [x] Doppler echocardiography
e) [ ] 3D echocardiography
---------------------------------------------------------------------
391. Intrebarea nr. 391: I54 Punctajul: 10CM Which of the following should be determined to
Page 76
76
assess pulmonary circulation:
a) [x] Right pulmonary diameter
b) [x] Distribution of pulmonary circulation
c) [ ] Spirography results
d) [ ] It can't be appreciated
e) [ ] The heart's arch
---------------------------------------------------------------------
392. Intrebarea nr. 392: I55 Punctajul: 10CM Select type of potential serological biomarkers
present in cardiovascular disease:
a) [x] Myocytes injury markers
b) [x] Markers of inflammation
c) [x] Oxidative stress markers
d) [ ] Intracellular remodeling markers
e) [ ] Psychological stress markers
---------------------------------------------------------------------
393. Intrebarea nr. 393: I56 Punctajul: 10CM Choose myocyte injury markers:
a) [ ] C-reactive protein
b) [x] Troponin I and T
c) [x] Myosin light chain kinase
d) [ ] Malondialdehyde
e) [ ] B natriuretic peptide
---------------------------------------------------------------------
394. Intrebarea nr. 394: I57 Punctajul: 10CM Choose myocyte stress markers:
a) [x] B natriuretic peptide
b) [ ] Malondialdehyde
c) [x] Proadrenomedulina
d) [ ] Troponin I and T
e) [ ] Interleukins
---------------------------------------------------------------------
395. Intrebarea nr. 395: I14 Punctajul: 10CS A serious complication of chronic renal failure is:
a) [ ] neoplastic pericarditis
b) [x] uremic pericarditis
c) [ ] hepatomegaly
d) [ ] tuberculous pericarditis
e) [ ] elevation
---------------------------------------------------------------------
396. Intrebarea nr. 396: I15 Punctajul: 10CS In neoplastic pericarditis the treatment includes:
a) [ ] Antibiotics
b) [ ] NSAIDs
c) [x] Chemotherapy
d) [ ] Antiviral
e) [ ] Antifungial ---------------------------------------------------------------------
397. Intrebarea nr. 397: I16 Punctajul: 10CS The most important feature of constrictive pericarditis
is:
a) [ ] noise of a falling drop
Page 77
77
b) [x] diastolic clacment
c) [ ] gallop rhythm
d) [ ] systolic blast
e) [ ] noise II in place of aortic valve auscultation
---------------------------------------------------------------------
398. Intrebarea nr. 398: I17 Punctajul: 10CS Tick the cause of cardiac tamponade:
a) [ ] bazal pneumonia
b) [ ] mitral Insufficiency
c) [x] uremia
d) [ ] hypertension
e) [ ] ventricular paroxysmal tachycardia
---------------------------------------------------------------------
399. Intrebarea nr. 399: I18 Punctajul: 10CS Tick the group of specific drugs in the treatment of
purulent pericarditis:
a) [x] Antibiotics
b) [ ] Diuretics
c) [ ] Analgesics
d) [ ] Antihypertensive
e) [ ] Diuretics
---------------------------------------------------------------------
400. Intrebarea nr. 400: I19 Punctajul: 10CS Specific forms of pericarditis are the following
except:
a) [ ] post myocardial infarction
b) [ ] uremic
c) [x] pre myocardial infarction
d) [ ] postirradiation
e) [ ] posttuberculosis
---------------------------------------------------------------------
401. Intrebarea nr. 401: I20 Punctajul: 10CS Viral diseases that cause infectious pericarditis are
following except:
a) [ ] Endemic mumps
b) [ ] Varicella
c) [ ] AIDS
d) [x] Viral meningitis
e) [ ] Infectious mononucleosis
---------------------------------------------------------------------
402. Intrebarea nr. 402: I21 Punctajul: 10CS ECG of evolution of stage III acute pericarditis is
characterized by:
a) [x] I, II, aVL with negative T waves
b) [ ] aVR, V1, V2 are negative T waves
c) [ ] aVR, V1, V2 ST segment depression
d) [ ] aVF, V3-V6 ST segment elevation
e) [ ] aVR, V1, V2 segment PR depression
---------------------------------------------------------------------
403. Intrebarea nr. 403: I22 Punctajul: 10CM Tick the method of diagnostics in acute pericarditis:
a) [x] EcoCG
Page 78
78
b) [x] Chest radiography
c) [x] Radionuclide study
d) [ ] Stress Test
e) [ ] Ventriculography
---------------------------------------------------------------------
404. Intrebarea nr. 404: I23 Punctajul: 10CM What is specific for the first stage of acute
pericarditis on ECG:
a) [x] aVR, V1-V2 is inverted T wave
b) [x] I, II, aVL T wave is positive
c) [x] aVF, V3-V6 ST segment elevation
d) [ ] I, II, III, aVL where T is negative
e) [ ] aVR, V1-V2 where T is positive
---------------------------------------------------------------------
405. Intrebarea nr. 405: I24 Punctajul: 10CM Which tests are used for the diagnosis of acute
pericarditis:
a) [x] HIV serological
b) [ ] Pancreatic enzymes
c) [ ] Thyroid balance
d) [ ] Diagnosis of autoimmune diseases
e) [x] Tuberculin testing, viral markers. ---------------------------------------------------------------------
406. Intrebarea nr. 406: I25 Punctajul: 10CM Pericardial effusion depends on the following
factors?
a) [ ] pacient's age
b) [x] the absolute volume of effusion
c) [x] physiologic features of the pericardium
d) [x] rate of fluid accumulation
e) [ ] frequency of cardiac contractions
---------------------------------------------------------------------
407. Intrebarea nr. 407: I26 Punctajul: 10CM Choose cardiac tamponade features:
a) [x] Increased pressure in the pericardium
b) [x] Progressive limitation of ventricular diastolic filling
c) [x] Reduction of stroke volume and cardiac output
d) [ ] Increased systolic volume
e) [ ] Increase in stroke volume and cardiac output ---------------------------------------------------------------------
408. Intrebarea nr. 408: I27 Punctajul: 10CM Clinical heart tamponade includes:
a) [x] profuse cold perspiration
b) [x] chest pain
c) [ ] bradycardia
d) [x] tachycardia
e) [ ] Musset sign
---------------------------------------------------------------------
409. Intrebarea nr. 409: I28 Punctajul: 10CM Clinical investigations administrated in suspection of
cardiac tamponade are the following:
a) [x] chest radiography
Page 79
79
b) [x] ecoCG
c) [ ] excretory urography
d) [ ] ophthalmoscopy
e) [x] pericardiocentesis
---------------------------------------------------------------------
410. Intrebarea nr. 410: I29 Punctajul: 10CM Possible mechanisms of uraemic pericarditis are:
a) [x] hyperfunction of parathyroid gland
b) [ ] hypercorticism
c) [ ] hypoglycemia
d) [x] metabolites of nitric catabolism
e) [ ] metabolites of protein anabolism
---------------------------------------------------------------------
411. Intrebarea nr. 411: I30 Punctajul: 10CM Neoplastic diseases leading to pericardial affection
includes:
a) [x] lung cancer
b) [x] leukemia
c) [ ] ovarian cyst
d) [ ] intestinal polyposis
e) [x] leiomyosarcoma
---------------------------------------------------------------------
412. Intrebarea nr. 412: I31 Punctajul: 10CM Tick the modes of involvement of the heart in cases
of neoplastic metastasis:
a) [x] extension and attaching of mediastinal malignant mass to the pericardium
b) [x] diffuse pericardial thickening and infiltration of tumor
c) [ ] heteregeneous lipid streaks
d) [ ] local depigmentation
e) [x] local infiltration of the pericardium
---------------------------------------------------------------------
413. Intrebarea nr. 413: I32 Punctajul: 10CM Tick the complications of pericarditis:
a) [ ] myocardial infarction
b) [x] recurrent episodes of pericardial inflammation
c) [x] fibrosis and calcified pericardium
d) [x] cardiac tamponade
e) [x] constrictive pericarditis
---------------------------------------------------------------------
414. Intrebarea nr. 414: I33 Punctajul: 10CM What laboratory investigations should be performed
in case of acute pericarditis?
a) [ ] Abdominal ultrasound
b) [ ] Bone Scintigraphy
c) [x] Chest radiography
d) [x] EcoCG
e) [x] ECG
---------------------------------------------------------------------
415. Intrebarea nr. 415: I404 Punctajul: 10CM Tick independence of the rhythm which kind of
extrasystoles are:
a) [ ] atrial
Page 80
80
b) [ ] ventricular
c) [x] solitaire
d) [x] doublets
e) [x] volleys
---------------------------------------------------------------------
416. Intrebarea nr. 416: I405 Punctajul: 10CM. Mention the characteristics of monomorphic
extrasystoles:
a) [ ] coupling intervals are different
b) [ ] extrasystoles, in the same deviation, have a different shapes
c) [x] extrasystoles are from the same outbreak
d) [x] coupling intervals are equal
e) [ ] extrasystoles are from different outbreaks
---------------------------------------------------------------------
417. Intrebarea nr. 417: I406 Punctajul: 10CS.Ventricular extrasystole on ECG is manifested by:
a) [ ] anormal QRS complex
b) [ ] incomplete compensatory pause
c) [ ] P - Q interval less than 0,12 sec
d) [ ] negative P wave, after QRS complex
e) [x] absence of P wave
---------------------------------------------------------------------
418. Intrebarea nr. 418: I407 Punctajul: 10CS.The upper atrioventricular extrasystole on the ECG
records:
a) [ ] P-Q interval more than 0,20 sec
b) [ ] abnormal QRS complex
c) [x] negative P wave in DII, DIII before QRS complex
d) [ ] negative P wave in DII, DIII after QRS complex
e) [ ] full compensatory pause
---------------------------------------------------------------------
419. Intrebarea nr. 419: I408 Punctajul: 10CS. Note the ECG manifestations of the middle
atrioventricular extrasystole:
a) [ ] abnormal QRS complex
b) [ ] negative P wave in DII, DIII after QRS complex
c) [x] P waveis embedded in QRS complex
d) [ ] full compensatory pause
e) [ ] negative P wave in DII, DIII before QRS complex
---------------------------------------------------------------------
420. Intrebarea nr. 420: I409 Punctajul: 10CS. The lower atrioventricular extrasystole on the ECG
records:
a) [ ] abcence of P wave
b) [ ] abnormal QRS complex
c) [ ] full compensatory pause
d) [x] negative P wave after QRS complexul
e) [ ] PQ interval more than 0,2 sec
---------------------------------------------------------------------
421. Intrebarea nr. 421: I410 Punctajul: 10CM. By periodicity extrasystoles are classified into:
a) [x] bigeminy
Page 81
81
b) [x] trigeminiy
c) [x] quadrigeminy
d) [ ] monomorphic
e) [ ] polymorphic
---------------------------------------------------------------------
422. Intrebarea nr. 422: I411 Punctajul: 10CS. Enumerate the mechanism of action of Class I
antiarrhythmic drugs
a) [ ] Potassium channel blockers
b) [x] Sodium channel blockers
c) [ ] Calcium channel blockers
d) [ ] β-blockers
e) [ ] Potassium channel blockers
---------------------------------------------------------------------
423. Intrebarea nr. 423: I412 Punctajul: 10CS. Note the mechanism of action of Class II
antiarrhythmic drugs
a) [ ] Potassium channel blockers
b) [ ] Sodium channel blockers
c) [ ] Calcium channel blockers
d) [x] β-blockers
e) [ ] Potassium channel blockers
---------------------------------------------------------------------
424. Intrebarea nr. 424: I413 Punctajul: 10CM. Note the mechanism of action of Class III
antiarrhythmic drugs
a) [x] Potassium channel blockers
b) [ ] Sodium channel blockers
c) [ ] Calcium channel blockers
d) [ ] β-blockers
e) [x] Potassium channel blockers
---------------------------------------------------------------------
425. Intrebarea nr. 425: I414 Punctajul: 10CS. Tick the mechanism of action of Class IV
antiarrhythmic drugs
a) [ ] Potassium channel blockers
b) [ ] Sodium channel blockers
c) [x] Calcium channel blockers
d) [ ] β-blockers
e) [ ] Potassium channel blockers
---------------------------------------------------------------------
426. Intrebarea nr. 426: I415 Punctajul: 10CS. Tick the antiarrhythmic drug that acts on the
"iF"channel
a) [ ] Amiodarone
b) [ ] Sotalol
c) [x] Ivabradine
d) [ ] Metoprolol
e) [ ] Nicorandil ---------------------------------------------------------------------
427. Intrebarea nr. 427: I416 Punctajul: 10CM. List the I-st Class antiarrhythmic drugs
Page 82
82
a) [x] Lidocaine
b) [x] Propafenone
c) [x] Quinidine
d) [x] Procainamide
e) [ ] Amiodarone
---------------------------------------------------------------------
428. Intrebarea nr. 428: I417 Punctajul: 10CM Specify the treatment of patients with chronic atrial
fibrillation require administration of the following drugs:
a) [ ] Amiodarone
b) [x] Digoxin
c) [x] Bisoprolol
d) [x] Warfarin
e) [ ] Amlodipine
---------------------------------------------------------------------
429. Intrebarea nr. 429: I418 Punctajul: 10CS. Choose the best method to patients with frequent
paroxysms of ventricular tachycardia require:
a) [ ] Pacemaker implantation
b) [ ] Transesophageal stimulation
c) [ ] Ablation
d) [x] Cardiodefibrillator implantation
e) [ ] Heart transplantation
---------------------------------------------------------------------
430. Intrebarea nr. 430: I419 Punctajul: 10CM. Mention whch score are used to thromboembolism
risk in a patient with atrial fibrillation
a) [ ] EHRA
b) [ ] SCORE
c) [x] CHADS2
d) [x] CHA2DS2-VASC
e) [ ] Framingham
---------------------------------------------------------------------
431. Intrebarea nr. 431: I420 Punctajul: 10CM. Call the signs that are included in the CHA2DS2
score, bythat is established thromboembolism risk in a patient with atrial fibrillation:
a) [x] Hypertension
b) [x] Heart failure
c) [x] Stroke
d) [x] Age more than 65 years
e) [ ] Peripheral arterial disease
---------------------------------------------------------------------
432. Intrebarea nr. 432: I421 Punctajul: 10CM. Tick the signs that are included in the
CHA2DS2VASc score, by that is established thromboembolism risk in a patient with atrial
fibrillation:
a) [x] Diabetes mellitus
b) [x] Heart failure
c) [x] Stroke
d) [x] Age more than 75 years
e) [ ] Viral hepatitis
Page 83
83
---------------------------------------------------------------------
433. Intrebarea nr. 433: I422 Punctajul: 10CM. List the parameters that differentiate
CHA2DS2-VASC score from CHADS2 by that is established thromboembolism risk in a patient
with atrial fibrillation:
a) [x] Myocardial infarction
b) [ ] Heart failure
c) [ ] Stroke
d) [x] Age
e) [x] Peripheral arterial disease
---------------------------------------------------------------------
434. Intrebarea nr. 434: I423 Punctajul: 10CS. Note the correct statement for alloritmia
estrasistolcă type bigeminy:
a) [x] Each of the 2-nd beat is an extrasystole
b) [ ] Each of the 3-nd beat is an extrasystole
c) [ ] Each of the 4-th beat is a extrasystole
d) [ ] Doublets
e) [ ] Triplets
---------------------------------------------------------------------
435. Intrebarea nr. 435: I424 Punctajul: 10CS. Choose the correct statement for alloritmia
estrasistolcă type trigeminy:
a) [ ] Each of the 2-nd beat is an extrasystole
b) [x] Each of the 3-nd beat is an extrasystole
c) [ ] Each of the 4-th beat is a extrasystole
d) [ ] Doublets
e) [ ] Triplets
---------------------------------------------------------------------
436. Intrebarea nr. 436: I425 Punctajul: 10CS. Choose the correct statement for arrhythmia
extrasistolica type quadrigeminy:
a) [ ] Each of the 2-nd beat is an extrasystole
b) [ ] Each of the 3-nd beat is an extrasystole
c) [x] Each of the 4-th beat is a extrasystole
d) [ ] Doublets
e) [ ] Triplets
---------------------------------------------------------------------
437. Intrebarea nr. 437: I426 Punctajul: 10CS. Suggests the correct statement for the ECG
arrhythmia manifested by the succession of three extrasystoles
a) [ ] Each of the 2-nd beat is an extrasystole
b) [ ] Each of the 3-nd beat is an extrasystole
c) [ ] Each of the 4-th beat is a extrasystole
d) [ ] Doublets
e) [x] Triplets
---------------------------------------------------------------------
438. Intrebarea nr. 438: I427 Punctajul: 10CS. Note the correct statement for the ECG arrhythmia
manifested by the succession of two extrasystoles
a) [ ] Each of the 2-nd beat is an extrasystole
b) [ ] Each of the 3-nd beat is an extrasystole
Page 84
84
c) [ ] Each of the 4-th beat is a extrasystole
d) [x] Doublets
e) [ ] Triplets
---------------------------------------------------------------------
439. Intrebarea nr. 439: I428 Punctajul: 10CS. Choose the correct statement for the ECG
arrhythmia manifested by extrasystolic triplets
a) [ ] Each of the 2-nd beat is an extrasystole
b) [ ] Each of the 3-nd beat is an extrasystole
c) [ ] Each of the 4-th beat is a extrasystole
d) [ ] The EKG present two successive extrasystoles
e) [x] The EKG present three successive extrasystoles
---------------------------------------------------------------------
440. Intrebarea nr. 440: I489 Punctajul: 10CS. Note the most common cause of angina occurrence:
a) [x] Atherosclerosis
b) [ ] Thrombosis
c) [ ] Bleeding
d) [ ] Carotid artery stenosis
e) [ ] Restenosis
---------------------------------------------------------------------
441. Intrebarea nr. 441: I490 Punctajul: 10CM. What painful forms of heart disease are:
a) [ ] Sudden death without cardiogenic shock
b) [ ] Old myocardial infarction
c) [ ] Silent Angina pectoris
d) [x] Vasospastic Angina pectoris
e) [x] late post infarction Angina pectoris
---------------------------------------------------------------------
442. Intrebarea nr. 442: I491 Punctajul: 10CM. List what painful forms of heart disease do not do
part:
a) [x] Sudden death without cardiogenic shock
b) [x] Old myocardial infarction
c) [x] Silent angina pectoris
d) [ ] Vasospastic agina pectoris
e) [ ] late post infarction angina pectoris
---------------------------------------------------------------------
443. Intrebarea nr. 443: I492 Punctajul: 10CM. Painless forms of heart disease are:
a) [x] Sudden death without cardiogenic shock
b) [x] Old myocardial infarction
c) [x] Silent Angina pectoris
d) [ ] Vasospastic Angina pectoris
e) [ ] Late post infarction Angina pectoris
---------------------------------------------------------------------
444. Intrebarea nr. 444: I493 Punctajul: 10CM. From painless forms of heart disease are not part:
a) [x] Sudden death with cardiogenic shock
b) [x] Acute myocardial infarction
c) [ ] Silent Angina pectoris
d) [x] Vasospastic Angina pectoris
Page 85
85
e) [x] Late post infarction Angina pectoris
---------------------------------------------------------------------
445. Intrebarea nr. 445: I494 Punctajul: 10CM. Painless forms of heart disease are:
a) [ ] Sudden death with cardiogenic shock
b) [x] Old myocardial infarction
c) [x] Silent Angina pectoris
d) [ ] Vasospastic Angina pectoris
e) [ ] Late post infarction Angina pectoris
---------------------------------------------------------------------
446. Intrebarea nr. 446: I495 Punctajul: 10CM. Choose correct statements characteristic for
aggravated angina:
a) [x] Pain is more frequent that in previous days
b) [x] Pains are of a longer duration as in previous days
c) [x] Pain occur at small effort and at rest as in previous days
d) [ ] Pain disappear at rest
e) [ ] Pain occurring in bigger effort than in previous days
---------------------------------------------------------------------
447. Intrebarea nr. 447: I496 Punctajul: 10CM. Choose correct statements for vasospastic angina:
a) [x] Pain is caused by stress
b) [x] Pain is longer than 15 minutes
c) [ ] Pain is mandatory caused byphysical exercise
d) [x] Pain is caused by cold temperature
e) [ ] Pain occur in bigger effort than in previous days
---------------------------------------------------------------------
448. Intrebarea nr. 448: I497 Punctajul: 10CS. Choose correct statement characteristic for early
post-infarction angina:
a) [ ] Angina appeared the first time after 3 weeks
b) [ ] Angina occurred the first time after 14 weeks
c) [x] Angina occurred in the 10th
days after acute myocardial infarction
d) [ ] Angina occurred in the 20th
days after acute myocardial infarction
e) [ ] Angina occurred in the 30th
days after acute myocardial infarction
---------------------------------------------------------------------
449. Intrebarea nr. 449: I498 Punctajul: 10CM. Choose correct statements for late post-infarction
angina:
a) [ ] Angina appeared the first time after 3 weeks
b) [ ] Angina occurred the first time after 14 weeks
c) [ ] Angina occurred in the 10th
days after acute myocardial infarction
d) [x] Angina occurred in the 20th
days after acute myocardial infarction
e) [x] Angina occurred in the 30th
days after acute myocardial infarction
---------------------------------------------------------------------
450. Intrebarea nr. 450: I499 Punctajul: 10CS. Choose correct statement for angina "de novo":
a) [x] Angina appeared the first time after 3 weeks
b) [ ] Angina occurred the first time after 14 weeks
c) [ ] Angina occurred in the 10th
days after acute myocardial infarction
d) [ ] Angina occurred in the 20th
days after acute myocardial infarction
e) [ ] Angina occurred in the 30th
days after acute myocardial infarction
---------------------------------------------------------------------
Page 86
86
451. Intrebarea nr. 451: I500 Punctajul: 10CM. Choose incorrect statements for angina "de novo":
a) [ ] Angina appeared the first time after 3 weeks
b) [x] Angina occurred the first time after 14 weeks
c) [x] Angina occurred in the 10th
days after acute myocardial infarction
d) [x] Angina occurred in the 20th
days after acute myocardial infarction
e) [x] Angina occurred in the 30th
days after acute myocardial infarction
---------------------------------------------------------------------
452. Intrebarea nr. 452: I1 Punctajul: 10CM Which of the following statements characterize
ischemic heart disease?
a) [ ] pathological proces is localized in pericardium
b) [ ] process is always acute
c) [x] pathological process in the coronary artery system
d) [x] over 90 % are caused by atherosclerosis
e) [x] blood circulation in the myocardium is reduced
---------------------------------------------------------------------
453. Intrebarea nr. 453: I2 Punctajul: 10CS Angina pectoris is the following, except:
a) [ ] transient myocardial ischemia clinical expression
b) [x] irreversible pathological changes
c) [ ] reversible pathological changes
d) [ ] manifested by painful crises, localized retrosternal
e) [ ] caused by disturbances of coronary circulation
---------------------------------------------------------------------
454. Intrebarea nr. 454: I3 Punctajul: 10CM The definition of effort angina pectoris include the
following:
a) [x] transient attacks of pain
b) [ ] cronic pain
c) [ ] pain increase by palpation of chest region
d) [x] caused by imbalance between myocardial oxygen supply and demand
e) [x] relieves at rest or during 5 min after administration of nytroglicerin
---------------------------------------------------------------------
455. Intrebarea nr. 455: I4 Punctajul: 10CM De novo effort angina represent:
a) [x] clinical variant of effort angina
b) [ ] clinical variant of myocardial infarction
c) [x] shown for one month from the time of the first attack
d) [ ] painful syndrome is more intense
e) [x] may regress, stabilize or progress
---------------------------------------------------------------------
456. Intrebarea nr. 456: I5 Punctajul: 10CS Functional class of effort angina is estimated in
relation to:
a) [ ] patient age
b) [ ] disease duration
c) [x] exercise tolerance
d) [ ] treatment given
e) [ ] smoking
---------------------------------------------------------------------
457. Intrebarea nr. 457: I6 Punctajul: 10CS Increased frequency, intensity and duration of angina
Page 87
87
attacks define:
a) [ ] silent angina pectoris
b) [x] instable angina pectoris
c) [ ] spontaneous angina pectoris
d) [ ] de novo effort angina
e) [ ] stable effort angina
---------------------------------------------------------------------
458. Intrebarea nr. 458: I7 Punctajul: 10CS What form of angina is coronary caused by spasm?
a) [ ] effort angina
b) [ ] de novo effort angina
c) [x] spontaneous angina pectoris (Prinzmetal)
d) [ ] worsening angina
e) [ ] silent angina
---------------------------------------------------------------------
459. Intrebarea nr. 459: I8 Punctajul: 10CM Select modifiable risk factors for ischemic heart
disease:
a) [ ] age
b) [x] smoking
c) [x] sedentary lifestyle
d) [ ] family history
e) [x] diet high in saturated fat ---------------------------------------------------------------------
460. Intrebarea nr. 460: I9 Punctajul: 10CM Select non-modifiable risk factors for ischemic heart
disease:
a) [ ] sedentary lifestyle
b) [ ] smoking
c) [x] age
d) [x] family history
e) [ ] diet high in saturated fats
---------------------------------------------------------------------
461. Intrebarea nr. 461: I10 Punctajul: 10CS Which of the 5 types of hyperproteinemia after
Fredrickson is associated strongly with coronary atherosclerosis?
a) [ ] type I
b) [x] type II and III
c) [ ] type I
d) [ ] types I and IV
e) [ ] type III
---------------------------------------------------------------------
462. Intrebarea nr. 462: I11 Punctajul: 10CS The III functional class acording Canadian
Cardiovascular Society used for classification of angina severity is:
a) [ ] Slight limitation, with angina only during vigorous physical activity
b) [x] Moderate limitation, symptoms with everyday living activities
c) [ ] Angina only during strenuous or prolonged physical activity
d) [ ] Inability to perform any activity without angina or angina at rest, ie, severe limitation
e) [ ] Accesses are long- up to 30 min
---------------------------------------------------------------------
Page 88
88
463. Intrebarea nr. 463: I12 Punctajul: 10CM Select the characteristics of microvascular angina:
a) [x] due to dysfunction of small coronary arteries and arterioles
b) [ ] caused by infection
c) [x] cardiac catheterization demonstrate normal or minimal atherosclerosis of coronary
arteries
d) [ ] caused by vascular spasm
e) [x] are believed to be caused by systemic collagen vascular diseases
---------------------------------------------------------------------
464. Intrebarea nr. 464: I13 Punctajul: 10CS Wich endothelial factor has the most powerful
vasoconstrictor effect?
a) [ ] prostacyclin
b) [x] endothelin
c) [ ] angiotensin II
d) [ ] nitrous oxide
e) [ ] thromboplastin
---------------------------------------------------------------------
465. Intrebarea nr. 465: I14 Punctajul: 10CM Note factors with procoagulant action responsible in
the pathogenesis of ischemic heart diseases:
a) [x] Tissue thromboplastin
b) [x] Willebrand factor
c) [x] Collagen
d) [x] Platelet activating factor
e) [ ] Thrombolisis
---------------------------------------------------------------------
466. Intrebarea nr. 466: I15 Punctajul: 10CS Electrocardiographic myocardial ischemia is
manifested by:
a) [ ] QRS deflection
b) [x] horizontal or down-sloping ST segment depression
c) [ ] PQ interval shortening
d) [ ] P wave amplitude decrease
e) [ ] ST segment elevation
---------------------------------------------------------------------
467. Intrebarea nr. 467: I16 Punctajul: 10CM Exercise stress testing is necessary in order to:
a) [ ] appreciate patient's quality of life
b) [x] classify functional class of angina pectoris
c) [x] confirm diagnosis of angina pectoris
d) [ ] assess the disease prognosis
e) [ ] select the treatment ---------------------------------------------------------------------
468. Intrebarea nr. 468: I17 Punctajul: 10CS Select the standard for evaluating the anatomy of the
coronary artery tree:
a) [ ] Exercise stress testing
b) [ ] ECG at rest
c) [x] Coronary angiography
d) [ ] Holter ECG monitoring
e) [ ] Echocardiografy
Page 89
89
---------------------------------------------------------------------
469. Intrebarea nr. 469: I18 Punctajul: 10CM What are the possibilities offered by
echocardiography exam?
a) [x] chambers diameters
b) [ ] determining the number of extrasystoles
c) [x] heart size and volume measurement compartments
d) [x] assessment interventricular septum thickness
e) [x] cusps state
---------------------------------------------------------------------
470. Intrebarea nr. 470: I19 Punctajul: 10CS What diagnostic method determines the indications
for angioplasty and aortocoronary bypass.
a) [ ] Holter monitoring
b) [ ] exercise stress testing
c) [ ] myocardial scintigraphy
d) [ ] echocardiography exam
e) [x] coronary angiography
---------------------------------------------------------------------
471. Intrebarea nr. 471: I20 Punctajul: 10CM Select groups of antianginal drugs:
a) [ ] diuretics
b) [x] nitrates
c) [x] Ca chanal blokers
d) [ ] statines
e) [x] beta blockers
---------------------------------------------------------------------
472. Intrebarea nr. 472: I21 Punctajul: 10CS Select the most common side effect of nitrates:
a) [ ] vertigo
b) [ ] sleepiness
c) [ ] abdominal pains
d) [x] headache
e) [ ] swelling on legs
---------------------------------------------------------------------
473. Intrebarea nr. 473: I22 Punctajul: 10CM What are the contraindications for administration of
β-blockers?
a) [ ] sinus tachycardia
b) [x] sinus bradycardia
c) [x] complete AV block
d) [ ] hypertension
e) [x] hypotension
---------------------------------------------------------------------
474. Intrebarea nr. 474: I23 Punctajul: 10CM Select the drugs from Calcium Channel Antagonists
group:
a) [ ] enalapril
b) [x] amlodipin
c) [x] diltiazem
d) [ ] metoprolol
e) [x] verapamil ---------------------------------------------------------------------
Page 90
90
475. Intrebarea nr. 475: I24 Punctajul: 10CS What is the primary first-choice antiplatelet drug used
to treat heart disease?
a) [ ] ticlopidine
b) [ ] dipyridamole
c) [ ] pentoxifylline
d) [x] aspirin
e) [ ] nicotinic acid
---------------------------------------------------------------------
476. Intrebarea nr. 476: I25 Punctajul: 10CS Simvastatin belongs to a group acting remedies:
a) [ ] antiagregant
b) [x] hypolipidemic
c) [ ] methabolic
d) [ ] hypotensive
e) [ ] vasodilator
---------------------------------------------------------------------
477. Intrebarea nr. 477: I26 Punctajul: 10CM Acute myocardial infarction is:
a) [x] myocardial necrosis
b) [x] a process caused by occlusion of a coronary artery
c) [x] one of the most common causes of mortality in the middle-age
d) [x] a pathological process developed in 80-90 % of cases with intravascular thrombosis
e) [ ] inflamation of miocardium
---------------------------------------------------------------------
478. Intrebarea nr. 478: I27 Punctajul: 10CS Right coronary artery occlusion causes myocardial
infarction:
a) [ ] anterior
b) [ ] antero- septal
c) [x] inferior
d) [ ] extended anterior
e) [ ] apical ---------------------------------------------------------------------
479. Intrebarea nr. 479: I28 Punctajul: 10CS Basic clinical manifestation of acute myocardial
infarction is:
a) [ ] dizziness
b) [x] retrosternal pain lasting more than 20 min
c) [ ] vomiting
d) [ ] fatigue
e) [ ] chest pain lasting 24 hours
---------------------------------------------------------------------
480. Intrebarea nr. 480: I30 Punctajul: 10CS The heart limits in acute myocardial infarction are
usually:
a) [ ] deviated to the right
b) [x] normal or a little deviated to the left
c) [ ] always is normal
d) [ ] normal or a little deviated to the right
e) [ ] normal or a little deviated to the left ---------------------------------------------------------------------
Page 91
91
481. Intrebarea nr. 481: I31 Punctajul: 10CS In myocardial infarction, with cardiogenic shock,
blood pressure will be:
a) [ ] elevated
b) [ ] various from case to case
c) [x] obviously low
d) [ ] normal
e) [ ] obviously increased
---------------------------------------------------------------------
482. Intrebarea nr. 482: I32 Punctajul: 10CS The formation of pathological Q waves on ECG
formation in acute myocardial infarction reflect the presence of the:
a) [x] area of necrosis
b) [ ] ischemic area
c) [ ] lesion area
d) [ ] parietal thrombus
e) [ ] left ventricle aneurysm
---------------------------------------------------------------------
483. Intrebarea nr. 483: I33 Punctajul: 10CS ST segment elevation in myocardial infarction
reflects the presence of the:
a) [ ] area of necrosis
b) [ ] ischemic area
c) [x] lesion area
d) [ ] parietal thrombus
e) [ ] left ventricle aneurysm
---------------------------------------------------------------------
484. Intrebarea nr. 484: I34 Punctajul: 10CM What statements characterize the initial phase of
acute myocardial infarction?
a) [x] lasts several hours
b) [ ] lasts several weeks
c) [x] ST segment elevation on ECG
d) [ ] ST segment is on isoline
e) [ ] the presence of pathological Q wave
---------------------------------------------------------------------
485. Intrebarea nr. 485: I35 Punctajul: 10CM The earliest recognised signs of acute myocardial
infarction on ECG are:
a) [x] Peaked T waves
b) [ ] ST segment depression on ECG
c) [x] ST segment elevation on ECG
d) [ ] ST segment returns to isoline
e) [ ] the T wave stabilization
---------------------------------------------------------------------
486. Intrebarea nr. 486: I36 Punctajul: 10CS In anteroseptal myocardial infarction direct ECG
signs are in the next leads:
a) [ ] V3 -V4
b) [x] V1-V3
c) [ ] V1-V4
d) [ ] II, III, AVF
Page 92
92
e) [ ] V 5-V6, I, AVL
---------------------------------------------------------------------
487. Intrebarea nr. 487: I37 Punctajul: 10CS In inferior myocardial infarction, direct ECG signs
are in the following leads:
a) [ ] V3 -V4
b) [ ] V1-V2
c) [ ] V1-V4
d) [x] II, III, AVF
e) [ ] 5-V6, I, AVL
---------------------------------------------------------------------
488. Intrebarea nr. 488: I38 Punctajul: 10CM Acording Universal Definition myocardial
infarction is detection of rise of biomarker values with at least one of the following:
a) [x] Symptoms of ischemia
b) [x] New or presumably new significant ST-T changes or new LBBB
c) [ ] New or presumably new PQ changes or new RBBB
d) [x] Imaging evidence of new loss of viable myocardium
e) [ ] Syncope
---------------------------------------------------------------------
489. Intrebarea nr. 489: I39 Punctajul: 10CM Select the ECG criteria for acute myocardial
infarction:
a) [ ] T wave inversion
b) [x] development of Q waves in the ECG
c) [ ] appearance of complete right bundle branch block
d) [ ] depression of ST segment
e) [x] elevation of ST segment lasting more than 24 hours
---------------------------------------------------------------------
490. Intrebarea nr. 490: I40 Punctajul: 10CS What laboratory changes are included in the criteria
for diagnosis of acute myocardial infarction?
a) [ ] C-reactive protein increase
b) [ ] Dislipidemia
c) [x] Rise cardiac biomarker
d) [ ] increased ESR
e) [ ] leukocytosis
---------------------------------------------------------------------
491. Intrebarea nr. 491: I41 Punctajul: 10CS What changes determine the differential diagnosis of
acute myocardial infarction with unstable pectoral angina?
a) [ ] character of pain
b) [ ] time of angina syndrome
c) [x] increased cardiac troponin
d) [ ] the effect of nitroglycerin administration
e) [ ] blood pressure figures
---------------------------------------------------------------------
492. Intrebarea nr. 492: I42 Punctajul: 10CM In contrast to acute pericarditis in acute myocardial
infarction:
a) [ ] pains increase to deep breathing
b) [x] appears pathological Q wave
Page 93
93
c) [x] rised cardiac troponin
d) [ ] ST segment elevation is consistent in all derivations
e) [x] ST segment elevation shound be found in two contiguous leads
---------------------------------------------------------------------
493. Intrebarea nr. 493: I43 Punctajul: 10CM Choose mechanical complications of acute
myocardial infarction:
a) [ ] Dressler syndrome
b) [x] Rupture of the heart
c) [x] Left ventricle aneurysm
d) [ ] Cardiogenic shock
e) [x] Trauma
---------------------------------------------------------------------
494. Intrebarea nr. 494: I44 Punctajul: 10CS AV block is developed more frequently in acute
myocardial infarction with localization:
a) [x] inferior
b) [ ] anterior
c) [ ] lateral
d) [ ] septal
e) [ ] anteroseptal ---------------------------------------------------------------------
495. Intrebarea nr. 495: I45 Punctajul: 10CS Postinfarction syndrome (Dressler) is an autoimmune
process, mainly with non-specific inflammation in:
a) [ ] myocardium
b) [x] pericardium
c) [ ] endocardium
d) [ ] mediastinum
e) [ ] vessels
---------------------------------------------------------------------
496. Intrebarea nr. 496: I46 Punctajul: 10CM The first emergency measures in acute myocardial
infarction provide:
a) [x] sublingual nitroglycerin, repeatedly
b) [x] aspirin 250-500 mg (first dose)
c) [ ] antibiotics
d) [ ] amiodaron
e) [x] oxygen
---------------------------------------------------------------------
497. Intrebarea nr. 497: I47 Punctajul: 10CM The reperfusion treatment in acute myocardial
infarction includes:
a) [x] thrombolytic drugs
b) [ ] aspirin 250-500 mg
c) [ ] anticoagulant drugs
d) [x] coronary angioplasty
e) [ ] ACE inhibitors
---------------------------------------------------------------------
498. Intrebarea nr. 498: I48 Punctajul: 10CS Note the intavenous bolus dose of unfractionated
heparin recommended in acute myocardial infarction:
Page 94
94
a) [x] 12 U/kg
b) [ ] 60 U/kg
c) [ ] 100 U/kg
d) [ ] 25 U/kg
e) [ ] the decizion of the physician
---------------------------------------------------------------------
499. Intrebarea nr. 499: I49 Punctajul: 10CM Select thrombolytic therapy recommended in acute
myocardial infarction:
a) [ ] heparin
b) [x] streptokinase
c) [x] alteplase
d) [ ] aspirin
e) [x] reteplase
---------------------------------------------------------------------
500. Intrebarea nr. 500: I50 Punctajul: 10CM Secondary prevention of myocardial infarction
includes:
a) [x] statins
b) [x] antiplatelet therapy
c) [x] β-blockers
d) [x] angiotensin converting enzymes inhibitors
e) [ ] diuretics
---------------------------------------------------------------------
![Page 1: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/1.jpg)
![Page 2: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/2.jpg)
![Page 3: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/3.jpg)
![Page 4: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/4.jpg)
![Page 5: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/5.jpg)
![Page 6: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/6.jpg)
![Page 7: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/7.jpg)
![Page 8: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/8.jpg)
![Page 9: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/9.jpg)
![Page 10: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/10.jpg)
![Page 11: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/11.jpg)
![Page 12: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/12.jpg)
![Page 13: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/13.jpg)
![Page 14: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/14.jpg)
![Page 15: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/15.jpg)
![Page 16: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/16.jpg)
![Page 17: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/17.jpg)
![Page 18: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/18.jpg)
![Page 19: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/19.jpg)
![Page 20: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/20.jpg)
![Page 21: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/21.jpg)
![Page 22: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/22.jpg)
![Page 23: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/23.jpg)
![Page 24: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/24.jpg)
![Page 25: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/25.jpg)
![Page 26: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/26.jpg)
![Page 27: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/27.jpg)
![Page 28: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/28.jpg)
![Page 29: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/29.jpg)
![Page 30: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/30.jpg)
![Page 31: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/31.jpg)
![Page 32: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/32.jpg)
![Page 33: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/33.jpg)
![Page 34: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/34.jpg)
![Page 35: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/35.jpg)
![Page 36: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/36.jpg)
![Page 37: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/37.jpg)
![Page 38: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/38.jpg)
![Page 39: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/39.jpg)
![Page 40: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/40.jpg)
![Page 41: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/41.jpg)
![Page 42: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/42.jpg)
![Page 43: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/43.jpg)
![Page 44: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/44.jpg)
![Page 45: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/45.jpg)
![Page 46: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/46.jpg)
![Page 47: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/47.jpg)
![Page 48: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/48.jpg)
![Page 49: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/49.jpg)
![Page 50: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/50.jpg)
![Page 51: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/51.jpg)
![Page 52: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/52.jpg)
![Page 53: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/53.jpg)
![Page 54: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/54.jpg)
![Page 55: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/55.jpg)
![Page 56: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/56.jpg)
![Page 57: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/57.jpg)
![Page 58: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/58.jpg)
![Page 59: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/59.jpg)
![Page 60: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/60.jpg)
![Page 61: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/61.jpg)
![Page 62: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/62.jpg)
![Page 63: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/63.jpg)
![Page 64: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/64.jpg)
![Page 65: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/65.jpg)
![Page 66: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/66.jpg)
![Page 67: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/67.jpg)
![Page 68: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/68.jpg)
![Page 69: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/69.jpg)
![Page 70: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/70.jpg)
![Page 71: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/71.jpg)
![Page 72: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/72.jpg)
![Page 73: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/73.jpg)
![Page 74: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/74.jpg)
![Page 75: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/75.jpg)
![Page 76: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/76.jpg)
![Page 77: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/77.jpg)
![Page 78: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/78.jpg)
![Page 79: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/79.jpg)
![Page 80: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/80.jpg)
![Page 81: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/81.jpg)
![Page 82: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/82.jpg)
![Page 83: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/83.jpg)
![Page 84: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/84.jpg)
![Page 85: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/85.jpg)
![Page 86: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/86.jpg)
![Page 87: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/87.jpg)
![Page 88: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/88.jpg)
![Page 89: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/89.jpg)
![Page 90: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/90.jpg)
![Page 91: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/91.jpg)
![Page 92: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/92.jpg)
![Page 93: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/93.jpg)
![Page 94: medicina2.usmf.md · 1 1. Intrebarea nr. 1: Intrebarea1 Punctajul: 10CS. Tick the characteristic ECG sign of sinus bradycardia: a) [ ] PQ interval 0.22 mm/sec b) [ ] Irregular RR](https://reader030.documente.net/reader030/viewer/2022041005/5eab16fb7a7ffc017d536989/html5/thumbnails/94.jpg)
![APROBAT - medicina2.usmf.md fileional de Credite de Studiu vQ8QLYHUVLWDWHDGH6WDWGH0HGLFLQ L) DUPDFLHÄ1LFRODH7HVWHPL DQX´ din Republica Moldova I. DISPOZI II GENERALE 1. 3UH]HQWXO5HJXODPHQWGHWHUPLQRUJDQL]DUHD](https://static.documente.net/doc/80x56/5e07d5464d847f30de1a7e01/aprobat-de-credite-de-studiu-vq8qlyhuvlwdwhdgh6wdwgh0hglflq-l-dupdflh1lfrodh7hvwhpl.jpg)